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Research Article 
 
Abstract 
Ficus racemosa is a traditional medicinal plant found in Southeast Asia and Australia. It is 
commonly known as 'gular'or ‘Dumur’. Owing to the presence of β-sitosterol it decreases the 
blood glucose concentration. Many active constituents isolated from different parts of this plant 
exhibit useful pharmacological activity. The objective of this dissertation is to identify the 
biological activity of the roots of an indigenous medicinal plant, viz., Ficus racemosa (Family: 
Moraceae) and to evaluate the possible phytochemical and pharmacological profiles of the 
crude extracts. Some chemical and biological researches on this plant have been conducted 
out so far, focusing mainly on the plant's bark and root. That's why the objective of this 
framework is to assess the different possibilities of developing new therapeutic targets from this 
plant's fruit that could be crucial for the treatment of many diseases. 
 
Keywords: Ficus racemosa, Phytochemical Screening, Thrombolytic Activity, Antimicrobial 
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1. Introduction 
 
1.1 Rationale and Objective of the Work  
Phytochemistry is a branch of Pharmacognosy, with chemical and biological characters, which 
study the obtaining of medicaments by natural or semi synthesis methods? The subject 
“Phytochemstry” deals with the chemical structures of secondary metabolites, their metabolism, 
and their distribution and biological functions [1]. 
Written records of plant use as therapeutic agents date back millennia. The ancient records are 
from Mesopotamia, and date back to around 2600 BC. These records are not just a case of one 
or two plant-based 'drugs' finding their way into common use, as the documents indicate that 
plants contained many drugs in use (up to 1,000 in the particular instance of Mesopotamia) [2]. 
Around 119 pure chemical substances extracted from the higher plants are used worldwide in 
medicine. In most medicinal herbs, fresh or dried parts, whole, chopped, powdered or an 
advanced form of the herb, usually produced by a solvent such as water, ethanol or organic 
solvent, play an important role and are the  backbone of traditional medicines [3]. 
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Figure 1. Ficus racemosa Tree 
 
Goals of using plants as sources of therapeutic agents are:  
To isolate bioactive compounds for direct use as drugs e.g. digoxin, digitoxin, morphine, 
reserpine, taxol, vincristine, vinblastine. 
1. To generate bioactive compounds of novel or known structures as semi-synthesized lead 
compounds to produce protectable entities with higher activity and/or lower toxic effects 
e.g. metformin, nabilone, oxycodone, taxotere, teniposide, verapamil and miodarone 
based on galegin, A9-tetrahydrocannabinol, morphine, taxol, podophyllotoxin, khellin. 
2. To use agents as pharmacologic tools e.g. lysergic acid diethylamide, mescaline [4]. 
There are several familiar approaches for lead searching from the plants and the isolated 
bioactive compounds are utilized in three basic ways: Unmodified medicinal plant products 
where ethnomedical uses suggested clinical efficacy e.g. digitoxin (a), digoxin (b), morphine 
(c). 
 
(a) Digoxin (source: Chemistry World) 
 
(b) Digitoxin (source: sciencedirect.com) 
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(c) Morphin (source: ChemSpider) 
Figure 2. Lead compound search & utilization from plants 
 
1. Unmodified natural products of which the therapeutic efficacy was only remotely 
suggested by folk medicine use e.g. vincristine. 
2. Modified natural or synthetic substances based on a natural product used in traditional 
medicine e.g. aspirin [5]. 
3. Terrestrial plants, especially higher plants, have a long history of use in the treatment of 
human diseases [6]. Fossil records date human use of plants as medicines at least to the 
Middle Paleolithic age some 60,000 years ago [7]. Several well-known species, including 
licorice (Glycyrrhiza glabra) myrrh (Commiphoraspecies), and poppy capsule latex 
(Papaver somnjferum), were referred to by the first known written record on clay tablets 
from Mesopotamia in 2600 BC, and these plants are still in use today for the treatment of 
various diseases as ingredients of official drugs or herbal preparations used in systems of 
traditional medicine. Furthermore, morphine, codeine, noscapine (narcotine), and 
papaverine isolated from P. somniferum were developed as single chemical drugs and are 
still clinically used. Hemisuccinate carbenoxolone sodium, a semi-synthetic derivative of 
glycyrrhetic acid found in licorice, is prescribed for the treatment of gastric and duodenal 
ulcers in various countries [6]. 
A careful selection of plants is conditioned by success in the research of natural products, 
based on various criteria such as chemotaxonomic data, ethnomedical information, field 
observations or even discrete collection [8]. Historical encounters with plants as therapeutic 
instruments helped to introduce particular chemical entities into modem medicine. Plants, 
especially those with ethnopharmacological have been the primary sources of medicines for 
early drug discovery. In fact, a recent sis by Fabricant and Farnsworth showed that the uses of 
80% of 122 plant-derived drugs were related to their original ethnopharmacological purposes. 
Current drug development from terrestrial plants has relied mainly on Bioactivity-guided isolation 
methods which have led, for example, to the discovery of essential anticancer agents, Taxus 
brevifolia paclitaxel and Camptotheca acuminate camptothecin [6]. The goals of using plants 
as sources of therapeutic agents are a) to isolate bioactive compounds for direct use as drugs, 
e.g. digoxin, digitoxin, morphine, reserpine, taxol, vinblastine, vincristine; b) to produce bioactive 
compounds of the novel or known structures as lead compounds for semisynthesis to produce 
patentable entities of higher activity and/or lower toxicity, e.g., metformin, nabilone, 
oxycodone (and other narcotic analgesics), Taxotere, teniposide, verapamil, and amiodarone, 
which are based, respectively, on galegine, D9- tetrahydrocannabinol, morphine, taxol, 
podophyllotoxin, and khellin; c) to use agents as pharmacologic tools, e.g., lysergic acid 
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diethylamide (LSD), mescaline, yohimbine; and d) to use the whole plant or part of it as a herbal 
remedy, e.g., cranberry, echinacea, feverfew, garlic, etc[9]. The number of higher plant species 
(angiosperms and gymnosperms) on this planet is estimated at 250,000[10].with a lower level at 
215,000 [11].and an upper level as high as 500,000[12].Of these, only about 6% have been 
screened for biologic activity, and a reported 5% have been evaluated phytochemically[13]. It 
was estimated that in 1991 in the United States, for every 10,000 pure compounds most likely 
those based on synthesis) that are biologically evaluated (primarily in vitro), 20 would be tested 
in animal models, and 10 of these would be clinically evaluated, and only one would reach U.S. 
Food and Drug Administration approval for marketing. The time required for this process was 
estimated at 10 years at a cost of $231 million (U.S.) [14]. The major drawback of this strategy is 
the frequent isolation of known metabolites. Therefore, hyphenated techniques (LC-UV, LC-MS, 
and LC-NMR have been developed; in order to detect is early as possible potential original 
structures. These compounds can then be tested in various bioassays [8]. More recently 
combinatorial chemistry and high throughput robotic screening techniques have been 
employed as viable strategies for drug discovery programs [15]. Chemical diversity of secondary 
plant metabolites that results from plant evolution is superior to at found in synthetic 
combinatorial chemical libraries [14]. Medicinal plants have played an essential role in the 
development of human culture, for example, religions and different ceremonies. (E.g. Datura 
has long been associated with the worship of Shiva, the Indian God). Plants are directly used as 
medicines by a majority of cultures around the world, for example, Chinese medicine and 
Indian medicine. Many food crops have medicinal effects, for example, garlic. Medicinal plants 
are resources of new drugs. Studying medicinal plants helps to understand the plant toxicity and 
protect humans and animals from natural poisons. Cultivation and preservation of medicinal 
plants protect biological diversity, for example, the metabolic engineering of plants [16]. The 
medicinal plants are used in the pharmaceutical, cosmetic, agricultural, and food industries. 
With the onset of scientific research into herbals, it becomes increasingly clear that medicinal 
herbs have potential in today's synthetic era, as numbers of medicines become resistant. 
According to one estimate, only 20% of the plant flora has been studied and 60% of synthetic 
medicines owe their origin to plants. Ancient knowledge coupled with scientific principles can 
come to the forefront and provide us with powerful remedies to eradicate the diseases. In the 
real sense, the coupling of ancient knowledge and scientific principle is essential- (1) to identify 
alternative and complementary medicine. (2) To reduce the toxicity of drug therapy especially 
toxicity reduction of synthetic and semi-synthetic drugs. (3) To find the lead compound 
diversification to treat various diseases [17]. 
 
1.2. History of traditional herbal medicine in Bangladesh  
Traditional Medicine is the medicine or treatment based on traditional uses of plants, animals or 
their products, other natural substances (including some inorganic chemicals), religious verses, 
cultural practices, and physical manipulations including torture. As this system of medicine has 
been in use almost unchanged generation after generation throughout the ages for the 
treatment of various physical and psychological diseases, it is called traditional. Most of the 
time, the type, preparation, and uses of traditional medicines are largely influenced by folklore 
customs and the cultural habits, social practices, religious beliefs, and, in many cases, 
superstitions of the people who prescribe or use them [18]. The earliest mention of traditional 
medicine is found in “Rigveda”, the oldest repository of knowledge in this subcontinent. Later 
“Ayurveda”, developed from the Vedic concept of life, became the important source of all 
systems of medical sciences. In course of time, it became a part of the culture and heritage of 
the people of the Indian subcontinent Traditional medicine involves the use of both material 
and non-material components. The material components invariably comprise parts or organs of 
Forestry & Agriculture Review 1 (2), 2020 
33 Published by Scientific Research Initiative, 3112 Jarvis Ave, Warren, MI 48091, USA  
 
plants and their products. They also consist of animal organs, minerals, and other natural 
substances. The non-material components, which constitute important items of religious and 
spiritual medicines, include torture, charms, magic, incantations, religious verses, amulets and 
rituals like sacrifices, appeasement of evil spirits, etc. [18]. Treatments in traditional medicine 
involve internal and external use of medicinal products, physical manipulation of different parts 
of the body, performing rituals, psychological treatment, and also minor surgery. Ayurvedic 
medicinal preparations consist mainly of powdered plant materials, semi-solid preparations, 
decoctions, elixirs, and distillate. Many of these also contain inorganic chemical substances, 
minerals, and products for animals. Ayurvedic medicine also uses alcoholic extracts and 
alcoholic solutions of the ingredients, tinctures and elixirs [18].  
Table 1.1: Some crude drugs used as medicine Bangladesh [20] 
Plant Biological 
Source 
Plant part in 
use 
Important content Use 
Punarnava Boerhaavia 
diffusa 
Root Alkaloids, Xanthenes, Ursolic acid Diuretic, useful in nephritic syndrome, 
chronic edema and liver diseases 
Vasaka Adhatoda 
vaska 
Dried/fresh 
leaves 
Vasicine, Vasicinone (alkaloid) Cough & cold, chronic bronchitis & 
asthma, expectorant 
Anantamul Hemidesmus 
indicus 
Root Essential Oil, Saponin, Resin, 
Tannins, Sterols and glucosides. 
Tonic,  diuretic, demulcent, 
diaphoretic, carminative 
Arjun Tarminalia 
arjuna 
Leaves & bark Tannins, β-sitosterols, saponin As cardio tonic in angina pain, diuretic in 
palpitations 
Chirata Gentiana 
chirayita 
Entire dried 
plant 
Gentiopicrin (bitter glycoside) Bitter tonic, febrifuge, stomachic & 
laxative 
Picrorhiga Picrirhiga kurroa Dried rizomes Picrorhigin (Glycoside) Bitter tonic, cathartic, stomachic used in 
dyspepsia, anti-periodic & colagogue 
Kalomegh Andrographis 
paniculata 
Leaves or 
entire aerial 
part 
Kalmeghin (bitter crystalline 
diterpin lactone) 
Febrifuge, astringent, anthelmintic. Useful 
in cholera, piles, gonorrhea, dyspepsia 
and general weakness 
Amla 
(Triphala) 
Phylanthus 
emblica 
Dried fruit Vit C (20 times more than in 
orange) 
Cooling, refrigerant, diuretic & laxative, 
promotes hair growth 
Bahera Terminalia 
belerica 
Dried ripe fruit 20% tannins, phyllembin, 
mannitol 
Bitter tonic, astringent, laxative, 
antipyretic used in dysentery, piles, 
leprosy 
Haritaki Terminalia 
Chebula 
Fruit Triterpenes & conjugated 
coumarins 
Carminative, appetite stimulant used in 
leprosy, anemia, piles, intermittent fever, 
heart disease, diarrhea 
Tulsi Ocimum 
sanctum 
Leaves Eugenol (essential oil), carvacrol Expectorant, diaphoretic, antiperiodic, 
antiseptic 
& spasmolytic 
Neem Azadiachta 
indica 
Leaves & seed 
oil 
Nimbin, nimbinene, nimbandiol 
(indole alkaloids) 
Stimulant, antiseptic used in rheumatism 
& skin diseases 
Garlic Alium sativum Bulb Designated allicin Used in hypertension, stimulating bile 
production, common cold, acceleration 
in wound healing 
Spirulina Spirulina 
maxima 
Blue-green 
algae 
Protein and Vit B12 Weight loss 
Ginseng Panax 
quinquefolius 
Root Complex mixture of triterpenoid 
saponins 
Aphrodisiac 
Aloe Aloe 
barbadensis 
Dried latex 
juice of leaves 
Barbaloin (anthraquinine 
glycosides) 
Benzoin tincture, cathartic 
The major constituents of Unani medicine are whole plants or their powders or pastes or 
products and their extracts, infusions, decoctions and distillates. In the preparation of these 
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medicines, minerals, inorganic chemicals, and animal products are also frequently used. The 
Indian subcontinent's medical knowledge is termed Ayurveda for hundreds of years. Plant 
alkaloids are the primary active ingredients of Ayurvedic drugs. Today, the pharmacologically 
active ingredients of many Ayurvedic medicines are being identified and their usefulness in drug 
therapy is determined. As only a certain percentage of plants are used in traditional medicines, 
it is roughly estimated that of the discovered 17,000 species, nearly 3,000 species are used in the 
medicinal field [19]. Some crude drugs used as medicine in Bangladesh are reported in table 
1.1. 
 
1.3. Research of traditional drugs in Bangladesh  
Medicinal plants have long been used in rural areas as a remedy for illness. Not only do they 
cure the disease but they also play an important part in the economy. Medicinal plants are 
cheap and easy to reach people who have known this very well. Bioactive molecules are 
deposited in medicinal plants; they can serve as important raw materials for the production of 
pharmaceutical products. They comprise a country's valuable asset and donate to its health-
care system. Well-judged and scientific research into this wealth can contribute significantly to 
public health. Besides being commodities available for trade. A country can also earn a good 
amount of foreign currency by exporting this natural wealth to other countries. More than 500 of 
such medicinal plants have so far been established as growing in Bangladesh [20]. Almost all of 
these indigenous medicinal plants are extensively used in the preparation of Unani, ayurvedic 
and homeopathic medicines in Bangladesh. A survey conducted in 1990 in various villages in 
Bangladesh shows that an average of 14% of people suffering from disease approach qualified 
allopathic doctors, 29% contact unqualified village doctors, 10% contact mullahs, 29% contact 
quack and 19% contact homeopaths. The survey shows extensive use by our people of 
medicinal plants, the majority of which are served in the crude and inferior form [21]. Traditional 
medicines are still manufactured in our country by following the age-old unscientific, traditional 
methods. Hundreds of traditional medicinal plants are employed in various Ayurvedic and Unani 
commercial preparations without proper standardization, quality control, assessment and 
perseverance of the chemical nature, pharmacological and toxicological studies of the active 
ingredients, which are essential for the full utilization of their medicinal properties. The toxicity of 
the plants or plant extracts is coming to light with the advancement of science. Since 
Bangladesh is a country of low economic growth, a proper health care system can be 
established by supplying low-cost medicines to its population. This may be possible only by 
developing standard drugs from our natural resources of medicinal plants. In order to achieve 
this goal research and development of traditional medicines should be given the due priority 
[20]. Besides, Bangladesh imports a large quantity of pharmaceutical raw materials including 
medicinal plants and semi-processed plant products to manufacture drugs. Each year a great 
deal of money is spent on this purpose. 
 
1.4. General Approaches to Drug Discovery from Natural Sources  
In general, three different approaches have been, and continue to be used in the drug 
discovery process from natural sources. These approaches are: traditional empirical and 
molecular [22]. The 'Susruta Samhita' and the 'Charaka Samhita' were influential works about 
traditional medicine during the Vedic period. Hundreds of medicinal plants have been 
identified and have traditionally been in use since. Ayurvedic practitioners have developed a 
number of medicinal preparations and surgical procedures for the treatment of various diseases 
and disorders over the following centuries. WHO estimates that 80% of populaces living in 
developing countries rely on traditional medication exclusively for their primary health care 
needs. Traditional plants play a major role in almost all herbal medicine and are the backbone 
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of traditional medicine. [23]. Examples include drugs like morphine, quinine and ephedrine that 
have been in widespread use for a long time, and more recently adopted compounds such as 
the antimalarial artemisinin. The empirical approach builds on an understanding of a relevant 
physiological process and often develops a therapeutic agent from a naturally occurring lead 
molecule. Examples include tubocurarine and other muscle relaxants, propranolol and other b-
adrenoceptor antagonists, and cimetidine and other H2 receptor blockers. The development of 
molecular biological techniques and the advances in genomics lead to a molecular approach. 
The molecular approach to drug discovery can be further subdivided into three general 
categories. The first is rational drug design using computer-aided techniques. A second area is 
the antisense approach, which is based on the manipulation of genetic targets. The third 
technique, which currently dominates drug discovery activity, is the pragmatic approach of 
random screening. With recent technological developments in molecular biology, 
instrumentation and information technology, screening of compounds can be conducted by a 
high throughput screening method. High throughput screening is an automated testing process 
of a large number of compounds versus a large number of targets which is particularly effective 
in identifying potential lead compounds. Robotics and miniaturization of in vitro tests on 
genetically modified cells have led to high throughput screening [22]. The major advantage of 
natural products for random screening is structural diversity. Since Bioactive natural products 
often occur as a part of a family of related molecules, it is, therefore, possible to isolate a 
number of homologs compounds and obtain a structure-activity relationship. Of course, lead 
compounds found from a screening of natural products can be optimized by traditional 
medicinal chemistry or by application of combinatorial approaches. Overall, when faced with 
molecular targets in screening assays for which there is no information about low molecular 
weight leads, use of a natural products library seems more likely to provide the chemical 
diversity to yield a hit than a library of similar numbers of compounds made by combinatorial 
synthesis. Since only a small fraction of the world’s biodiversity has been tested for biological 
activity, it can be assumed that natural products will continue to offer novel leads for novel 
therapeutic agents[22].In earlier times, all drugs and medicinal agents were derived from 
natural substances, and most of these remedies were obtained from higher plants. Today, many 
new chemotherapeutic agents are synthetically derived, based on “rational” drug design. The 
study of natural products has advantages o’er synthetic drug design in that it leads optimally to 
materials having new structural features with novel biological activity. Not only do plants 
continue to serve as important sources of new drugs, but phytochemicals derived from them 
are also extremely useful as lead structures for synthetic modification and optimization of 
bioactivity. The starting materials for about one-half of the medicines we use today come from 
natural sources. Virtually every pharmacological class of drugs includes a natural product 
prototype. The future of plants as sources of medicinal agents for use in the investigation, 
prevention, and treatment of diseases is very promising [24]. 
 
1.5. Phytotherapy 
The treatment of diseases by the use of the plants is known as phytotherapy. Phytotherapy was 
the beginning of pharmacotherapy or treatment of disease by means of drugs. Therapeutics 
uses of plants had in effect stored at the very beginning of human life on the earth when the 
primitive man out of necessity and by intuition, restored to using plants to alleviate suffering from 
injuries and diseases [25]. Phytotherapy laid the foundation stone of all from of medical 
treatment that are practiced today. With the development of human civilization of 
phytotherapy exhibits a stepwise development, which can be enumerated as- 
1st stage: Crude drugs were employed, prepared in the roughest manner, such as powdered 
willow in the management of pain.  
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2nd stage:  These were converted into more active and manageable forms, such as extracts or 
solutions watery or alcoholic.  
3rd stage: The pure active principles separated from crude drug were employed e.g. salicylic 
acid.  
4th stage: Attempt to synthesize the active drug in the laboratory and indeed structural 
modification. e.g.  Aspirin. 
 
1.6. Medicinal plants and drug development  
Development of drugs from medicinal plants is often an elaborate laborious time consuming 
and expensive exercise. Careful phytochemical analysis and pharmacological and clinical tests 
are pre-requisites for developing drugs from medicinal plants. The stage involve in the following 
way development exercise may be summarize as follows:  
 Selection and correct identification of the proper medicinal plants and its extraction with 
a suitable solvent.  
 Detection of biological activity of the crude extent and establishment of a bioassay 
system to permit the identification of the active fractions and rapid discarding of the 
inactive ones.  
 Fraction of the crude extracts by using physico-chemical procedure and monitored by 
biological tests identification and separation of the active fractions.  
 Isolation of the active constituents by chromatographic or other technique and 
purification of the isolation compounds by repeated chromatography and crystallization.  
 Establishment of the chemical structures of the pure compound by various 
physicochemical techniques and determination of their biological activity by various 
pharmacological tests.  
 
1.7. Contribution of medicinal plants to modern drug  
Plants have contributed and are still contributing to the development of modern synthetic drugs 
and medicine in a number of ways as stated below:  
 Novel structure of biologically active chemical compounds isolated from plants sources, 
often to prompt the chemists to synthesis similar or better semi —synthetic compounds.  
 Synthetic drugs with similar or more potent therapeutic activity are often prepared by 
structural modification of the plant derived compound with known biological activity. 
 Chemists for use as potent drugs often prepare various analogues of derivatives of plant 
constituents with similar or better pharmacological action and therapeutics properties.  
Homatropine (a synthetic tropane alkaloid similar to atropine) syrosingopine (a synthetic 
derivative of reserpine) chloroquine (a synthetic derivative of quinine) dihydromorphinone, 
oxymorphone, methyldihydromorphinone, ethyl morphine and N-allylnormorphine (synthetic 
derivatives of morphine) are some of the examples of such synthetic drug which plants have 
contributed indirectly. Even in this age of synthetic drug, there are some naturally occurring 
drugs, such as the Digitalis glycoside used in cardiac complications and the Catharanthus 
alkaloids used in cancers, which have no synthetic alternatives. In such cases, plants continue 
to remain as their principal and oily sources. 
 
1.8. Status of medicinal plants of Bangladesh  
 About 500 medicinal plants have been reported to occur in Bangladesh  
 Almost 80% of rural populations are dependent on medicinal plants for their primary 
health care.  
 The local people conserve traditional knowledge through their experience and practices 
which is handed down orally without any documentation. 
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 The over exploitation of wild medicinal plants has become a threat to its extinction.  
 In Bangladesh there is no systematic cultivation process of conservation strategies about 
medicinal plants.  
 There is no government policy or rules and regulations about the medicinal plants 
cultivation conservation and marketing.  
 There are almost 422 herbal medicinal companies using medicinal plants as raw materials 
mostly by importing from abroad.  
 
1.9. Chemical constituents of medicinal plants  
The commonly occurring chemical substances which are responsible for the medicinal (as well 
as toxic) properties of plants include the following- 
 Volatile or essential oils  
 Fixed oils  
 Gum-resins and mucilage  
 Alkaloid and amines  
a) Pyridine group  
b) Tropane group  
c) Isoquiloline group  
d) Quinoline group  
e) Quinolizidile group  
f) Indole group  
g) Steroidal group  
h) Phenylethylamine group  
i) Alkaloid amines  
 Glycosides:  
a) Anthraquinone glycoside  
b) Cardiac glycoside  
c) Saponin glycoside Thiocyanate glycoside  
d) Other glycoside  
 Vitamin and mineral 
 
1.10. Flow Chart of Bioactivity Guided Phytochemical Approach 
 
Figure 3. Flow Chart of Bioactivity Guided Phytochemical Approach 
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The objective of this dissertation is to identify the biological activity of the roots of an indigenous 
medicinal plant, viz., Ficus racemosa (Family: Moraceae) and to evaluate the possible 
phytochemical and pharmacological profiles of the crude extracts. So far some chemical and 
biological investigations have been carried out on this plant mainly focusing on the bark and 
root of the plant. That’s why the goal of this framework is to explore the potential possibilities of 
developing new drug candidates from the fruit of this plant which could be crucial for the 
treatment of various ailments. 
 
2. Plant Preview 
2.1. The plant family: Moraceae 
Ficus racemosa is an attractive fig tree with a crooked trumk and a spreading crown. Unlike the 
banyan, it has no aerial roots. The most distinctive aspect of this tree is the red, furry figs in short 
clusters, which grow directly out of the trunk of the tree [26]. 
Leaves: The leaves are dark green, 6-10 cm long, glabrous; receptacles small subglobose or 
piriform, in large clusters from old nodes of main trunk.  
Fruits: The fruits receptacles are 3-6 cm in diameter, pyriform, in large clusters, arising from main 
trunk or large branches. The fruits resemble the figs and are green when raw, turning orange, 
dull reddish or dark crimson on ripening. The fruit of Ficus racemosa Linn is 3/4inch to 2 inches 
long, circular and grows directly on the trunk [27]. 
Flowers: Looking for the flower of Ficus racemosa should know that the fig is actually a 
compartment carrying hundreds of flowers. One might wonder how these flowers enclosed in a 
ball are pollinated. The flowers are pollinated by very small wasps that crawl through the 
opening in search of a suitable place to reproduce (lay eggs). Without this pollinator service fig 
trees cannot reproduce by seed. In turn, the flowers provide a safe haven and nourishment for 
the next generation of wasps. 
Seeds: The seeds are tiny, innumerable and grain-like. Outer surface of the bark consists of easily 
removable translucent flakes grayish to rusty brown, uniformly hard and non-brittle.  
Bark: Bark is reddish grey or grayish green, soft surface, uneven and often cracked, 0.5-1.8 cm 
thick, on rubbing white papery flakes come out from the outer surface, inner surface light 
brown, fracture fibrous, taste mucilaginous without any characteristic odour. Unlike the banyan, 
it has no aerial roots. Those looking for the flower of goolar should know that the fig is actually a 
compartment carrying hundreds of flowers [28]. 
Roots: The roots of F. racemosa are long, brownish in color. It’s having characteristic odor and 
slightly bitter in taste Roots are irregular in shape.  
 
2.1.1 Vernacular names 
Scientific Name: Ficus racemosa 
Synonyms: Ficusracemosa var. mollis, Ficusglomerata 
Bengali: Dumor, Udumbara (উদমু্বর) 
English: Gular fig, Country Fig, Cluster Fig 
Gujarati: Goolar, Umbaro 
Hindi: Dumar, Jantu Phal, Goolar, Goolar, Pani Bhuj, Pushp-hina, Udumbara, Dharma Patra, 
Umari 
Malayalam: Aththi, Udumbaram, Atthi, Jantuphalam, Atthi-al 
Other name: Dumrii, Redwood Fig, Indian Fig, Cluster Fig, Atteeka, Goolar, Vellaiatthi, Crattock, 
Country Fig, Gular Fig, Rumbodo, Athi 
Oriya: Dimri 
Tamil: Anai, NallaAtthi, MalaiyinMunivan, VellaiAtthi, Atti, Utumparam, Atti 
Telugu: Atti, Bodda, Brahmamamidi 
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Urdu: Dumar 
 
2.1.2 Recent taxonomic revisions of the family include these genera: [29][30]. 
 Ficus chittagonga  
 Ficus glomerata  
 Ficus glomerata var. chittagonga 
 Ficus glomerata var. elongata  
 Ficus glomerata var. miquelii  
 Ficus glomerata var. mollis 
 Ficus goolereea  
 Ficus henrici  
 Ficus lanceolata  
 Ficus lucescens  
 Ficus mollis 
 Ficus racemosa var. miquelii 
 Ficus racemosa var. mollis 
 Ficus racemosa var. vesca (F. Müll. ex Miq.) Barrett 
 Ficus semicostata  
 Ficus trichocarpa 
 
2.2 Classification (Ficusracemosa L. Taxonomic Serial No.: 506544) 
Domain: Eukaryota 
        Kingdom: Plantae 
              Sub-kingdom: Viridiplantae 
                    Phylum: Magnoliophyta 
                          Sub-phylum: Euphyllophytina 
                                Infra-phylum: Radiatopses 
                                      Division: Tracheophyta 
                                            Class: Magnoliopsida 
                                                  Subclass: Magnoliidae 
                                                        Order: Rosales 
                                                              Family: Moraceae 
                                                                       Genus: Ficus 
                                                                            Species: Ficusracemosa 
 
 
Figure 4.  Ficus racemosa plant (source: Tropical Ferns). 
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Figure 4. The flowers of Ficusracemosa (source: Ayushvedah). 
 
 
Figure 5. Leaves of Ficusracemosa  
Source: Alchetron 
2.3 Plant Description 
Ficus racemosa, 20 to 30 m high; bole buttressed; bark 8-10 mm thick, surface reddish-brown or 
yellowish-brown smooth, coarsely flaky, fibrous; blaze creamy pink; latex milky; young shoots 
and twigs finely white hairy, soon glabrous; branchlets 1.5-3 mm thick, tuberculous [31].Leaves 
simple, alternate, stipules 12-18 mm long, lanceolate, linear-lanceolate, pubescent, often 
persistent on young shoots; petiole 10-50 mm long, slender, grooved above, becoming brown 
scurfy; lamina 6-15 x 3.5-6 cm, ovate, obovate, elliptic-oblong, elliptic-lanceolate, elliptic-ovate 
or oblong-ovate, base acute, obtuse or cuneate, apex narrowed, blunt or acute, margin entire, 
membranous, glabrous, blistered appearance on drying; 3-ribbed from the base, 4-8 pairs, 
slender, pinnate, prominent beneath, intercostal reticulate, obscure. Flowers unisexual; 
inflorescence a syconium, on short leafless branches or warty tubercles of the trunk or on larger 
branches, subglobose to pyriform, smooth, often lenticellate-verrucose; peduncle 3-12 mm long, 
stout, orifice plane or slightly sunken, closed by 5-6 apical bracts; internal bristles none; basal 
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bracts 3, 1-2 m long, ovate, triangular, obtuse, persistent; flowers of unisexual, 4 kinds; male 
flowers near the mouth of receptacles, in 2-3 rings, sessile, much compressed; tepals 3-4, 
dentate-lacerate, lobes jointed below, red, glabrous; stamens 2, exserted; filaments 1 mm, 
connate below; anthers oblong, parallel; female flowers sessile or very shortly stalked among 
gall flowers; tepals 3-4, dentate-lacerate, lobes jointed below, red, glabrous, ovary superior, 
sessile or substipitate, red-spotted; style 2-3 mm long, glabrous, simple; stigma clavate; gall 
flowers long-stalked; ovary dark red, rough; style short[32].Syconium 2.5 x 2 cm, orange, pink or 
dark crimson; achene granulate. 
Scientific name: Ficus racemosa. 
Common name: Dumor. 
Family: Moraceae 
Plant type: Evergreen and Shrub 
Origin: The plant is found in Bangladesh, India, Pakistan, China, Myanmar, Thailand, Indonesia, 
Vietnam, Australia etc. 
Ecology: Ficus racemosa a well-known medicinal plant commonly known as Dumor in Bengali is 
indigenous to Bangladesh. The farmers on the roadside and fallen land can also cultivate 
Ficusracemosa. This bush grows in all parts of the worlds. This plant occurs throughout 
Bangladesh. This shrub grows on the plains of Bangladesh and in the lower regions, up to a 
range of 1000 meters above sea level. This plant is also cultivated in other tropical areas. It is also 
distributed in India, Myanmar, Thailand Indonesia Vietnam, Australia etc. 
Cultivation: Ficus species are common and form an important element of lowland rain forest, 
both as canopy and understorey trees. Most species prefer per-humid forest, but several are 
found in areas with a monsoon climate and in teak forest, including locations where the soil 
dries out. Succeeds in full sun to partial shade. Succeeds in most soils that are reasonably moist 
but well-drained. Cluster fig is resistant to fire. 
 Parts used: Root, leaf, flower, fruit are used for therapeutic use. The leaves, roots, flowers and 
stem bark of this plant are used in medicinal applications. 
 
2.5 Chemistry of the plant Ficus racemosa 
Racemosa Linnspecies contain flavanoid glycosides, alkaloids , phenolic acids , steroids , 
saponins , coumarins , tannins , triterpinoids – oleanolic acid rusolic acid , α- hydroxy ursolic acid 
, protocatechuic acid , maslinic acid . The nonenzymatic constituents include phenolic 
compounds, flavonoids, vitamin C. The enzymatic constituents present are ascorbate oxidase, 
ascorbate peroxidise, catalase, peroxidise. The phenolic compounds present are gallic acid 
and ellagic acid [33]. 
 
2.6 Medicinal uses of the plant Ficus racemosa 
 The leaves are used in the treatment of diarrhea. 
 The bark is astringent. It is used in the treatment of hematuria, menorrhagia, and hemoptysis. 
 The fruit is astringent. It is used in the treatment of hematuria, menorrhagia, and hemoptysis. 
The fruit, when filled with sugar, is considered to be very cooling. 
 A fluid that exudes from the cut roots of the tree is considered to be a powerful tonic when 
drunk for several days together. The sap is a popular remedy in Bombay that is applied 
locally to mumps and other inflammatory glandular enlargements, and is also used in the 
treatment of gonorrhea. 
 The root is chewed as a treatment for tonsillitis. 
 
2.6.1 Medicinal Applications of the plant Ficus racemosa 
A few of the health benefits derived from figs include- 
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Prevention of constipation: There are 5 grams of fiber in every three-fig serving. That high 
concentration of fiber helps promote healthy, regular bowel function and prevents constipation. 
Fiber works to add bulk and mass to bowel movements, so it not only prevents constipation but 
also eliminates diarrhea and unhealthy or irregular bowel movements. 
Weight loss: The fiber in Ficus racemosa also helps to reduce weight and is often recommended 
for obese people. However, their high-calorie count can also result in weight gain, especially 
when consumed with milk. A few figs are enough to get the recommended amount of nutrients, 
so don’t overdo it! Remember, it is possible to have too much of a good thing. 
Lower cholesterol: Ficus racemosa contain Pectin, which is a soluble fiber. When fiber moves 
through the digestive system, it basically mops up excess clumps of cholesterol and carries them 
to the excretory system to be eliminated from the body. As a soluble fiber, pectin from figs also 
stimulates healthy bowel movements. Figs can have a laxative effect, as they are one of the 
most fiber-dense foods available. High amounts of fiber in your diet can benefit your overall 
health by preventing certain types of abdominal cancer, as well as colon cancer. 
Prevention of coronary heart disease: Dried figs contain phenol, Omega-3 and Omega-6. These 
fatty acids reduce the risk of coronary heart disease. Furthermore, the leaves of figs have a 
significant effect on the level of triglycerides in a person’s system. Figleaves have an inhibitory 
effect on triglycerides and makes the overall number of triglycerides drop. Triglycerides are 
another major factor behind various heart diseases. 
Prevention of colon cancer: The presence of fiber helps to stimulate the elimination of free 
radicals and other cancer-causing substances, particularly in the colon, since fiber increases the 
healthy movement of the bowels. 
Protection against post-menopausal breast cancer: Fiber content in figs have been known to 
protect against breast cancer, and after menopause, the hormonal balance in women can 
often fluctuate. The body’s systems are so interconnected that hormones affect the immune 
system, which in turn affects the ability of antioxidants to fight free radicals. Free radicals are 
prime factors behind the development of cancer, so figs take care of one extra line of defense 
by providing its wealth of fiber. 
Good for diabetic patients: The American Diabetes Association recommends figs as a high fiber 
treat that helps promote functional control of diabetes. Figleaves reduce the amount of insulin 
needed by diabetic patients who have to regularly take insulin injections. Ficus racemosa is rich 
in Potassium, which helps to regulate the amount of sugar which is absorbed into the body after 
meals. Large amounts of potassium can ensure that blood sugar spikes and falls are much less 
frequent, so figs can help diabetics live a much more normal life. 
Prevention of hypertension: People usually take in sodium in the form of salt, but low potassium 
and high sodium level may lead to hypertension. Figs are high in potassium and low in sodium, so 
they are a perfect defense against the appearance and effects of hypertension, making figs a 
relaxing food as well, which can settle the nerves and bring some calmness to your day. 
Bronchitis: The natural chemicals in Ficus racemosa leaves make it an ideal component for a tea 
base. Fig leaf tea has been popularly prescribed for various respiratory conditions like bronchitis, 
and it is also used as a way to prevent and lessen the symptoms of asthmatic patients. 
Venereal Diseases: Figs have been traditionally used in the Indian subcontinent and a few other 
areas of the world as a calming salve for venereal diseases. Ingestion or topical application both 
work for relief from sexually transmitted diseases, although further research needs to be done on 
the exact range of symptoms and diseases which figs positively effect. 
Sexual Dysfunction: For centuries, Ficus racemosa has been recommended as a way to correct 
sexual dysfunction like sterility, endurance, or erectile dysfunction. It has been a major part of 
mythology and culture, and most of the time, it is referenced as a powerful fertility or sexual 
supplement. Its actual success as an aphrodisiac is questionable, but the huge number of 
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valuable vitamins and minerals might result in the sudden boost in energy and stamina that 
people mistake for a sexual surge. Soak 2-3 figs in milk overnight and eat them in the morning to 
enhance your sexual abilities. 
Strengthens Bones: Ficus racemosa is rich in calcium, which is one of the most important 
components in strengthening bones and reducing the risk of osteoporosis. It is also rich in 
phosphorus, which encourages the bone formation and spurs regrowth if there is any damage or 
degradation to bones. 
Urinary calcium loss: People that maintain a high-sodium diet may be affected by increased 
urinary calcium loss. The high potassium content in figs helps to avoid that condition and 
regulates the content of waste in urine and minimizes the calcium lose while increasing the 
amount of uric acid and other harmful toxins that you want to get out of your body. 
Prevention of macular degeneration: Vision loss in older people is normally due to macular 
degeneration. Fruits and figs are particularly good at helping you avoid this very common 
symptom of aging. 
 
2.6.2 Pharmacological Activities of Ficus racemosa 
Antimicrobial activity 
Methanolic extracts of Ficus racemosa showed significant activity against four clinical strains of 
bacteria Staphylococcus aureus, Bacillus subtilis, Proteus vulgaris, and E. coli. The standard drug 
used was tetracycline (100 mcg/ml). In both the cases, the methanolic extracts at dose 
concentration of 500µg/ml showed significant antimicrobial activity. 
Analgesic activity 
Saponin (SN) isolated from Ficus racemosa flowers exhibited protection from writhing induced 
by 1.2% v/v acetic acid in Adult    Swiss albino mice. SN1 was administered ip at doses of 30, 50, 
75 and 100 mg/kg and standard drug used were aspirin, paracetamol and morphine sulphate. 
In hot plate method, SN not only produced analgesia in mice but also potentiated the 
analgesic action of pentazocine and aspirin [34]. 
Antibacterial activity 
The methanol extract of flowers of the plant have been screened for their antibacterial activity. 
The extract (7.5 mg/disc) showed broad-spectrum antibacterial activity against gram positive 
and gram-negative bacteria. The results were compared with the standard drug streptomycin 
(10 μg/ disc). The zone inhibition was found to be increased with the increase in concentration 
of the extract and thus exhibiting concentration dependent activity [35]. 
 
3. Preparation of Plant Extract 
 
3.1 Biological investigation of the experimental plants 
 A plant species representing to the family: Ficus racemosa was investigated in this study. 
Name of plant Family Plant part 
Ficus racemosa Moraceae Flower 
The investigations of the plant will be discussed in two different sections. 
 Phytochemical Investigation, and 
 Biological Investigation. 
3.2 Biological investigation of Ficus racemosa 
3.2.1 Collection and preparation of the plant material 
The whole plant of Ficus racemose was collected from Khamarbari, Farmgate, Dhaka and 
identified by taxonomist of   National Herbarium, Bangladesh situated at Mirpur in Dhaka. The 
sample is preserved in the Phytochemical Laboratory of World University of Bangladesh for as 
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further reference (Accession No. 41878). For several days, the fruit air dried and then the oven 
dried for 24 hours at considerably low temperatures (not more than 400C) for better grinding. In 
the Phytochemical Research Laboratory, Faculty of Pharmacy, World University of Bangladesh 
(WUB), the dried fruits were then ground to a coarse powder using high-capacity grinding 
machine.  
 
3.2.2 Extraction of the plant material 
The powdered material (250 gm) was taken in a cleaned, amber colored reagent bottle (5 
liters) and soaked in 1.5 L of methanol. The container with its content was sealed by bottle cap 
and kept for a period of 10 days accompanying occasional shaking and stirring. The whole 
mixtures were then filtered through a fresh cotton plug and finally with a Whatman No.1 filter 
paper. The volume of the filtrate was then allowed to evaporate at ambient temperature until 
approximately 70% solvent was evaporated.  
 
3.2.3 Solvent-Solvent partition of crude extract by Modified Kupchan Partition method  
Solvent-solvent partitioning was done using the protocol designed by Kupchan [36].The crude 
extract (5 gm) was dissolved in 10% aqueous methanol. It was extracted with Petroleum ether, 
then with carbon tetrachloride and finally with Chloroform. The whole partitioning process is 
schematically shown in Figure 3.1. All the five fractions were evaporated to dryness (Table 3.1) 
and were used for further analysis.  
 
3.2.3.1 Partitioning with Petroleum ether 
The mother solution was taken in a separating funnel. 100 ml of the Petroleum ether was added 
to it and the funnel was shaken and then kept undisturbed. The organic portion was collected. 
The process was repeated thrice and the fractions collected were evaporated together in 
Rotary evaporator.  
 
3.2.3.2 Partitioning with Carbon Tetrachloride 
To the mother solution left after partitioning with petroleum ether, 12.5 ml of distilled water was 
added and mixed. The mother solution was then taken in a separating funnel and extracted 
with carbon tetrachloride (100 ml x3). The carbon tetrachloride fractions were collected 
together and evaporated. The aqueous fraction was preserved for the next step. 
 
3.2.3.3. Partitioning with Chlorofom 
 
 
 
 
 
 
 
 
 
(a)                                              (b)                                         (c) 
(a) CHCl3 Soluble Fraction 
(b) Carbon Tetra Chloride Soluble Fraction 
(c) (c) Petroleum Ether Soluble Fraction 
Figure 6. Partitioning of plant extract 
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Figure 7. Schematic representation of the modified Kupchan Partitioning of crude extract of root 
of Ficus racemose 
 
Table 3.2: Fractions obtained from Ficus racemosa extract 
Plant part Sample code Fraction 
Flowers of Ficus racemosa 
MESF Methanol extract 
PESF Pet-ether soluble fraction 
CTCSF Carbon tetrachloride soluble fraction 
CSF Chloroform soluble fraction 
AQSF Aqueous Soluble Fraction 
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Figure 8. Different fractions of Ficus racemosa  
Source: Authors’ own work 
 
4. Design of biological Investigation 
4.1 General Approaches to Drug Discovery from Natural Sources 
Natural products have been the most successful source of drugs ever. Research progressed 
along two major lines: ethnopharmacology (medicinal herbs, substances of abuse, ordeal 
poisons) and toxicology (poisonous plants, venomous animals, arrow and fish poisons). 
These strategies have already produced many valuable drugs and are likely to continue to 
produce lead compounds. Approximately 60% of the world’s population relies entirely on 
plants for medication [37]. Of the 520 new drugs accepted between 1983 and 1994, 39 
percent were organic or derived from natural products and 60–80 percent were derived 
from natural products. Thirteen drugs related to natural products were approved between 
2005 and 2007, and five of these represented the first members of new drug classes: 
peptides exenatide and ziconotide, and the small molecules ixabepilone, retapamulin. 
There is also current commercial evidence supporting the case for natural products. Of the 
20 best-selling non-protein drugs in 1999, nine were either derived from or developed as a 
result of naturally occurring leads simvastatin, lovastatin, enalapril, pravastatin, atorvastatin, 
augmentin, ciprofloxacin, clarithromycin and cyclosporin with combined annual sales of 
>US$16 billion. Newer developments based on natural products include the antimalarial 
drug artemisinin and the anticancer agent’s taxol, docetaxel and camptothecin [38].  
 
4.2 Investigations  
The crude extract was subjected for chemical group tests and identified for - steroids, alkaloids, 
tannins, gums, flavonoids, reducing sugar and saponins. Results of different group tests are given 
in table 4.1. 
 
 
 
PESF CTCSF AQSF CSF MESF 
MESF 
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Table 4.1 Results of different chemical group test of the Methanol extract of Ficus racemosa 
Sample   
 
Test solution Observation Inference 
Tests for Alkaloids: 
0.2 ml of dilute hydrochloric acid 
1 ml of Mayer’s reagent. 
 
Yellowish colored 
precipitate was 
obtained 
Presence of alkaloid. 
 
0.2 ml of dilute hydrochloric acid. 
1 ml of Dragendroff’s reagent. 
 
Orange brown 
precipitate was 
observed. 
Presence of alkaloid. 
 
solution of the extract and 
0.2 ml of dilute hydrochloric acid 
1 ml of Hanger’s reagent. 
 
Yellowish precipitate 
was obtained. 
Presence of alkaloid. 
Test for Steroids: 
olution of chloroform 
extract 
1 ml of chloroform & few drops 
of con. Sulfuric acid 
 
Red color was observed. 
 
Presence of steroid. 
 
Test for Flavonoids: 
extract. 
Few drops of lead acetate was 
added to the extract. 
 
Yellow color was formed. 
 
Presence of 
Flavonoids. 
 
Test for Saponins: 
diluted with distilled water to 20 
ml. 
Shaken in a graduated cylinder 
for 15 minutes 
 
One-centimeter layer of 
foam was formed. 
 
Presence of 
saponins. 
 
Tests for Tannins: 
t. 
1 ml of 5% Ferric chloride 
solution. 
Greenish black 
precipitate was formed. 
Presence of tannins. 
 
 1 ml of 10% potassium 
dichromate solution. 
Yellow precipitate was 
obtained. 
Presence of tannins. 
 
 1 ml of 10% led acetate solution. Yellow precipitate Presence of tannins. 
 
Test for Reducing Sugars: 
extract. 
 
2 ml equal volume of Fehling’s A 
and B solution. 
Boiled for 5 minutes on a boiling 
water bath. 
Brick red colored 
precipitate was found. 
 
presen of reducing 
sugars. 
 
Test for Gums : 
 
 
1ml molisch reagent and 1ml 
con. Sulfuric acid were added. 
Red violet ring was 
produced at the 
junction of two liquids. 
Presence of gums 
 
 
4.3 Results & Discussions  
Phytochemical studies showed that Alkaloids, Steroids, Flavonoids, Tannins, Saponin, Gum & 
Reducing sugars are present in the methanol extract of the plant. The experimental findings 
from the study showed that the methanol extract has some important groups and secondary 
metabolites that can show extensively pharmacological activity. The medicinal properties of 
plants have been investigated in the recent scientific developments throughout the world due 
to their-  
 
4.3.1 Microbiological investigations 
With the help of an in vitro antimicrobial study, the antibacterial as well as antifungal spectrum 
of the crude extracts can be determined by observing the growth response. These studies are 
based on the fact that many infections are caused by bacteria and pillows and if the test 
materials inhibit bacterial or fungal growth, they can be used in these infections.  
However, a number of factors can influence the results like- 
 The extraction method  
 Inocula volume,  
 Culture medium composition, 
 pH and  
 Incubation temperature 
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4.3.2 Thrombolytic activity investigation 
Cerebral venous sinus thrombosis (CVST) is a common disorder that is often accompanied by 
significant morbidity and mortality. In anticoagulation therapy the intravenous heparin is the first 
line of treatment for CVST, because of its efficacy, safety and feasibility. However, thrombolytic 
therapy with its ability to produce rapid clot lysis has long been considered as an attractive 
alternative. Thrombolytic drugs like tissue plasminogen activator (t-PA), urokinase, streptokinase 
etc. play a crucial role in the management of patients with CVST. 
 
4.3.3 Membrane stabilizing activity investigation 
Inflammatory cells produce a complex mixture of growth differentiation cytokines as well as 
physiologically active arachidonate metabolites. They also have the ability to generate reactive 
oxygen species (ROS) that can damage cellular biomolecules, thus increasing the inflammatory 
state [39]. Erythrocyte membrane is similar to lysosomal membrane and, for example, the effect 
of drugs on erythrocyte stabilization can be extrapolated to the stabilization of lysosomal 
membrane [40] Therefore, when the membrane stabilizes, it interferes with the release and 
action of mediators such as histamine, serotonin, prostaglandin, leukotrins, etc.  [41]. 
 
4.3.4 Analgesic activity investigation 
Due to having adverse side effects like gastric lesion caused by NSAIDs and tolerance and 
dependence induced by opiates, the use of these drugs as analgesic agents have not been 
successful in all the cases. So, analgesic drugs are being searched all over the world as 
alternatives to NSAIDs and opiates. The investigation of the efficacy of plant based drugs used 
as traditional medicines have been paid great attention because they are- 
 Cheap 
 Have little side effects 
 According to WHO, about 80% of the world’s population rely mainly on plant based drugs? 
So in these dissertation two types of analgesic activity has been evaluated- 
 Peripheral analgesic activity 
 Central analgesic activity 
 
4.3.5 Hypoglycemic activity investigation 
The origin of the term is Greek: “hyper”, meaning excessive; “glyc”, meaning sweet; and 
“emia”, the meaning of the blood Hyperglycemia, or high blood sugar, is a condition in which 
an excessive amount of glucose circulates in the blood plasma. This is generally a glucose level 
higher than (120 mg/dl) but symptoms may not start to become noticeable until even higher 
values such as 250–300 mg/dl. A subject with a consistent range above 126 mg/dl is generally 
held to have hyperglycemia. Chronic levels exceeding 125 mg/dl can produce organ damage 
[42]. Despite considerable progress in the management of diabetes mellitus by synthetic drugs, 
the search for improved and safe natural anti-diabetic agents is ongoing. The plant kingdom 
offers a wide field to look for oral hypoglycemics. More than 400 species have been reported to 
display hypoglycemic effects, but only a few of them have been investigated [43].and the 
World Health Organization has recommended that this area warrants attention [44]. 
 
4.3.6 Anti-diarrheal activity investigation 
Diarrhea is characterized by an increase in the frequency of bowel movements, wet stools and 
abdominal pain. It is the world's third-largest killer disease, contributing significantly to pediatric 
morbidity and mortality, especially in the undernourished. The incidence of diarrhea is still high 
(about 7.1 million per year), despite the effort of the international organization to control the 
disease. Thus in this study, the anti-diarrheal activity was investigated by giving the plant 
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extractives. Here, the plant extractive causes the inhibition of excessive peristaltic movement 
induced by oral administration of castor oil. 
 
5. Evaluation of Total Phenolic content (TPC) 
 
5.1 Introduction 
Nature has been a source of medicinal agents for thousands of years and an impressive number 
of modern drugs have been isolated from natural sources, many of which are based on their 
uses in traditional medicine. Plants produce a diverse array of bioactive molecules that are 
particularly important in the treatment of life-threatening conditions [45]. Oxidation reactions 
initiated by excess free radicals have been shown to lead to the formation of tumors, damage 
of DNA, mRNA, proteins, enzymes; cause cancer, cardiovascular diseases, nervous disorders, 
premature aging, Parkinson’s and Alzheimer's diseases, rheumatic and pulmonary disorders[46]. 
Therefore, the need for systematic screening of medicinal plants for antioxidant activity cannot 
be overemphasized. Free radicals are atoms or groups of atoms that have at least one 
unpaired electron, making them highly reactive. The potentially reactive derivatives of oxygen 
are known as reactive oxygen species (ROS) (e.g. superoxide anions, hydrogen peroxide and 
hydroxyl, nitric oxide radicals), and play an important role in oxidative damage to various 
biomolecules including proteins, lipids, lipoproteins and DNA, related to the pathogenesis of 
various important diseases such as diabetes mellitus, cancer, atherosclerosis, arthritis, and 
neurodegenerative diseases and also in the aging process. Antioxidants are the substance that 
when present in low concentrations compared to those of an oxidizable substrate significantly 
delays or prevents oxidation of that substance. Antioxidants prevent the oxidative damage by 
directly reacting with ROS, quenching them and/or chelating catalytic metal ions and also by 
scavenging free oxygen. Since ancient times, many herbs have been potentially used as an 
alternative remedy for the treatment of many infections, diseases and as food preservatives 
suggesting the presence of antimicrobial and antioxidant constituents [47]. There is an 
increasing interest in the antioxidants effects of compounds derived from plants, which could be 
relevant in relation to their nutritional incidence and their role in health and diseases [48]. Plants 
are the potential source of natural antioxidants. Natural antioxidants or phytochemical 
antioxidants are the secondary metabolites of plants. Carotenoids, flavonoids, cinnamic acids, 
benzoic acids, folic acid, ascorbic acid, tocopherols, tocotrienols etc., are some of the 
antioxidants produced by the plant for their sustenance. Beta-carotene, ascorbic acid and 
alpha-tocopherol are the widely used antioxidants. Different synthetic antioxidants such as tert-
butyl-1-hydroxytoluene (BHT), butylated hydroxyanisole (BHA), propyl gallate (PG) and tert-butyl 
hydroquinone (TBHQ) used as food additives to increase shelf life are known to have not only 
toxic and carcinogenic effects in humans but abnormal effects on enzyme systems. Therefore, 
the interest in natural antioxidants, especially of plant origin, has greatly increased in recent 
years. Plant polyphenols have been studied largely because of the possibility that they might 
underlie the protective effects afforded by fruit and vegetable intake against cancer and other 
chronic diseases. Due to the complex nature of phytochemicals, the antioxidant activity of 
plant extracts must be assessed by combining two or more different In-vitro assays. A number of 
publications on the isolation and testing of plant-derived antioxidants have been characterized 
over the last decade. The purpose of this study was to evaluate different extractives of roots of 
Ficus racemosa as new potential sources of natural antioxidants and phenolic compounds 
today, many new chemotherapeutic agents are synthetically derived, based on "rational" drug 
design. The study of natural products has advantages over synthetic drug design in that it leads 
optimally to materials having new structural features with novel biological activity. Not only do 
plants continue to serve as important sources of new drugs, but phytochemicals derived from 
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them are also extremely useful as lead structures for synthetic modification and optimization of 
bioactivity. 
 
5.2 Assays for total phenolic content 
The antioxidant effect is mainly due to phenolic compounds such as flavonoids, phenolic acids 
and phenolic diterpenes. Phenolic compounds exert their antioxidant properties by redox 
reactions, which may play an important role in the absorption and neutralization of free 
radicals, the quenching of singlet and triplet oxygen, or the decomposition of peroxides. Many 
phytochemicals have strong antioxidant capabilities that may be associated with lower 
incidence and lower rates of cancer mortality in a number of human populations. Phenolic 
compounds are secondary metabolites of plants and can act as antioxidants through many 
potential pathways, such as radical scavenging, oxygen radical absorption, and chelating of 
metal ions [49]. 
 
5.2.1 Principle 
Phenols ionize completely in the alkaline state. When the Folin-Ciocalteu reagent is used in this 
ionized phenolic solution, the reagent will easily oxidize the phenols. The usual color of the Folin-
Ciocalteu reagent is yellow and the solution becomes blue after the oxidation process. The 
intensity of the color change is measured at 760 nm in the spectrophotometer. The absorbance 
value will reflect the total phenolic content of the compound [50]. 
 
Figure 9. Folin Ciocalteu Reagent Reaction with Phenol (Source: PNGitem) 
 
5.2.2: Materials & Methods 
Total phenolic content of root of Phytochemical and biological investigations of Ficusracemosa 
extractives was measured employing the method as described earlier [51] involving Folin-
Ciocalteu reagent as oxidizing agent and gallic acid as standard [52]. 
 
5.2.2.1 Materials 
 Folin-Ciocalteu reagent (10 fold 
diluted) 
 UV-spectrophotometer 
 Na2CO3 solution (7.5 %)  Vial 
 tert-butyl-1-hydroxytoluene (BHT)  Beaker (100 & 200ml) 
 Ascorbic acid  Test tube 
 Methanol  Pipette (1ml) 
 Chloroform  Pipette (5ml) 
 Carbon tetra chloride  Micropipette (50-200 µl) 
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 Pet-ether  
 Distilled water 
 
 
5.2.2.2 Composition of Folin-Ciocalteu reagent  
 
Table 5.1: Composition of Folin-Ciocalteu reagent [53] 
SL. No. Component Percent 
1 Water 57.5 
2 Lithium Sulfate 15.0 
3 Sodium Tungstate Dihydrate 10.0 
4 Hydrochloric Acid≥25% 10.0 
5 Phosphoric Acid 85 % solution in 
water 
5.0 
6 Molybdic Acid Sodium Dihydrate 2.5 
 
5.2.3. Standard curve preparation 
Gallic acid was used here as standard. Different gallic acid solutions were prepared having a 
concentration ranging from 100 µg / ml to 0 µg / ml. 2.5 ml of Folin-Ciocalteu reagent (diluted 10 
times with water) and 2.0 ml of Na2CO3 (7.5 % w/v) solution was added to 0.5 ml of gallic acid 
solution. The mixture was incubated for 20 minutes at room temperature. After 20 minutes the 
absorbance was measured at 760 nm. After plotting the absorbance in ordinate against the 
concentration in abscissa a linear relationship was obtained which was used as a standard 
curve for the determination of the total phenolic content of the test samples. 
 
5.2.4. Sample preparation 
2 mg of the extractives was taken and dissolved in the distilled water to get a sample 
concentration of 2 mg / ml in every case. The samples along with their concentration for the 
total phenolic content measurement are given in the Table 5.2. 
 
Table-5.2: Test sample for total phenolic content determination 
Plant part Sample 
code 
Test Sample Calculated 
amount 
(mg/ml) 
 
Flowers of 
Ficus 
racemosa 
MESF 
 
Methanol extract of fruits of 
Ficusracemosa 
2.0 
PESF Pet-ether soluble  fraction 2.0 
CTCSF Carbon tetrachloride soluble fraction 2.0 
AQSF Aqueous soluble fraction 2.0 
 
5.2.5 Total phenolic content analysis 
To 0.5 ml of extract solution (conc. 2 mg/ml), 2.5 ml of Folin-Ciocalteu reagent (diluted 10 times 
with water) and 2.0 ml of Na2CO3 (7.5 % w/v) solution was added. The mixture was incubated for 
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20 minutes at room temperature. After 20 minutes the absorbance was measured at 760 nm by 
UV-spectrophotometer and using the standard curve prepared from gallic acid solution with 
different concentration, the total phenolic content of the samples was measured. The phenolic 
contents of the sample were expressed as mg of GAE (gallic acid equivalent) / gm of the 
extract [54]. 
 
Figure 10. Schematic representation of the total phenolic content determination 
 
5.3 Results and discussion of the test samples of fruits of Ficusracemosa 
 
5.3.1 Total phenolic content (TPC) 
The methanolic extract of Ficus racemosa (MESF) and different partitionates i.e. petroleum ether 
(PESF), carbon tetrachloride (CTCSF), and aqueous (AQSF) soluble partitionates to total phenolic 
content determination. Based on the absorbance values of the various extract solutions, 
reacted with Folin-Ciocalteu reagent and compared with the standard solutions of gallic acid 
(table 5.3) equivalents, results of the colorimetric analysis of the total phenolics are given in 
(table 5.4). Total phenolic content of the samples are expressed as mg of GAE (gallic acid 
equivalent)/ gm of extractives. 
Table-5.3: Standard curve preparation by using gallic acid 
x = GA Conc. (μg/ml) y = Absorbance Regression curve 
equation 
R² 
100.000 1.620 y = 0.016x + 0.021 0.998 
50.000 0.866 
25.000 0.450 
12.500 0.253 
6.250 0.120 
3.125 0.059 
1.563 0.034 
0.781 0.022 
0.391 0.02 
0.000 0.011 
The amount of total phenolic content differed in different extractives and ranged from 4 mg of 
GAE /gm of extractives to 25.43 mg of GAE /gm of extractives of Ficus racemosa Among all 
extractives of Ficus racemosa the highest phenolic content was found in CTCSF (77.63 mg of 
GAE /gm of extractives) followed by AQSF (49.44 mg of GAE /gm of extractives).Significant 
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amount of phenolic compounds were also present in MESF (56.13 mg of GAE /gm of 
extractives), PESF (51.19 mg of GAE /gm of extractives) are also found. 
 
Figure 11. Standard curve of gallic acid for total phenolic content   determination  
Source: Authors’ own work 
 
Table-5.4: Test samples for Total phenolic content (TPC) determination 
 
Figure 11. Total phenolic content (mg of GAE / gm of extractives) of different extractives of leaf 
of Ficus racemosa  
Source: Authors’ own work 
y = 0.0162x + 0.0215
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code 
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Total phenolic content (mg of GAE / gm 
of extractives 
 
Fruits of Ficus 
racemosa 
MESF Methanol extract of the fruits of  Ficus racemosa 56.13 
PESF Petroleum ether soluble  fraction 51.19 
CTCSF Carbon tetrachloride soluble fraction 77.63 
AQSF Aqueous soluble fraction 49.44 
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6. Antimicrobial Activity: 
 
6.1 Introduction 
Infectious disease is one of the main causes of death accounting for approximately one-half of 
all deaths in tropical countries worldwide. Perhaps, it is not surprising to see these statistics in 
developing nations, but what may be remarkable is that infectious disease mortality rates are 
actually increasing in developed countries, such as the United States. Death from infectious 
disease ranked 5th in 1981, has become the 3rd leading cause of death in 1992; an increase of 
58%. It is estimated that infectious disease is the underlying cause of death in 8% of the deaths 
occurring in the US [55]. This is alarming given that it was once believed that we would eliminate 
the infectious disease by the end of the millennium. The increases are attributed to increases in 
respiratory tract infections and HIV/AIDS. Other contributing factors are an increase in antibiotic 
resistance in nosocomial and community-acquired infections. Furthermore, the most dramatic 
increases are occurring in the 25-44 years old age group [55]. These negative health trends call 
for a renewed interest in infectious disease in the medical, public health communities and 
renewed strategies on treatment and prevention. It is the last solution that would encompass 
the development of new antimicrobials [56]. The antimicrobial screening which is the first stage 
of antimicrobial drug research is performed to ascertain the susceptibility of various fungi and 
bacteria to any agent. This test measures the ability of each test sample to inhibit the in vitro 
fungal and bacterial growth. This ability may be estimated by any of the following three 
methods [57]. Disc diffusion method- 
 Serial dilution method 
 Bioautographic method 
But there is no standardized method for expressing the results of antimicrobial screening [58]. 
Some investigators use the diameter of zone of inhibition and/or the minimum weight of extract 
to inhibit the growth of microorganisms. However, a great number of factors viz., the extraction 
methods, inoculums volume, culture medium composition, pH, and incubation temperature can 
influence the results [59]. Among the above mentioned techniques, the disc diffusion is a widely 
accepted in vitro investigation for preliminary screening of test agents which may possess 
antimicrobial activity [59]. It is essentially a quantitative or qualitative test indicating the 
sensitivity or resistance of the microorganisms to the test materials. However, no distinction 
between bacteriostatic and bactericidal activity can be made by this method [60]. 
 
6.2 Principle of disc diffusion method 
In this classical method, antibiotics diffuse from a confined source through the nutrient agar gel 
and create a concentration gradient. Dried and sterilized filter paper discs (6 mm diameter) 
containing the test samples of known amounts are placed on nutrient agar medium uniformly 
seeded with the test microorganisms. Standard antibiotic (Ciprofloxacin) discs and blank discs 
are used as the positive and negative control. These plates are kept at low temperature (4°C) 
for 24 hours to allow maximum diffusion of the test materials to the surrounding media [61]. The 
plates are then inverted and incubated at 37°C for 24 hours for optimum growth of the 
organisms. The test materials having antimicrobial property inhibit microbial growth in the media 
surrounding the discs and thereby yield a clear, distinct area defined as a zone of inhibition. The 
antimicrobial activity of the test agent is then determined by measuring the diameter of the 
zone of inhibition expressed in millimeter [59], [61]. In the present study the crude extracts, as 
well as fractions, were tested for antimicrobial activity by the disc diffusion method. The 
experiment is carried out more than once and the mean of the readings is required [59]. 
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6.3 Experimental  
 
6.3.1 Apparatus and reagents 
 
 
 
 
 
 
 
 
 
 
 
6.3. 2 Test organisms 
The bacterial and fungal strains used for the experiment were collected as pure cultures from 
the State University of Bangladesh. Both gram positive and gram-negative organisms were 
taken for the test and they are listed in the table 6.1. 
 
Table 6.1: List of organisms 
Gram positive bacteria 
Bacillus subtilis 
Sarcina lutea 
Staphylococcus aureus 
Bacillus cereus 
Gram negative bacteria 
Escherichia coli 
Shigella dysenteriae 
Vibrio mimicus 
Vibrio parahemolyticus 
Salmonella typhi 
 
Nutrient agar medium is the most frequently used and also used in the present study for testing 
the sensitivity of the organisms to the test materials and to prepare fresh cultures. 
 
6.3.5 Preparation of the medium 
In order to prepare the required volume of this medium, the calculated amount of each of the 
components was taken in a conical flask and the distilled water was added to make the 
required volume. The contents were heated in a water bath to provide a clear solution. The pH 
(at 250C) was adjusted to 7.2-7.6 using NaOH or HCl. 10 ml and 5 ml of the medium were then 
transferred to the screw cap test tubes for the preparation of plates and slants. The test tubes 
were then capped and sterilized by 15-lbs autoclaving. Pressure at 1210C for about 20 minutes. 
Slants were used for the production of fresh culture of bacteria and fungi, which were then used 
for the sensitivity study. 
 
6.3.6 Sterilization procedure 
Antimicrobial screening has been performed in Laminar Hood in order to prevent any type of 
contamination and cross-contamination by the test organisms and all types of precautions 
have been very well maintained. One hour before working in the Laminar Hood, UV light was 
switched on. Petridishes and other glassware were sterilized by autoclaving at a temperature of 
 Filter paper discs  Autoclave 
 Nutrient Agar Medium  Laminar air flow hood 
 Petri-dishes  Spirit burner 
 Sterile cotton  Refrigerator 
 Micropipette  Incubator 
 Inoculating loop  Chloroform 
 Sterile forceps  Ethanol 
 Screw cap test tubes  Nose mask and Hand gloves 
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121oC and a pressure of 15 lbs / sq. Twenty minutes inch. Micropipette tips, cotton, forceps, 
blank disks, etc. were also sterilized by UV light [62]. 
 
6.3.7 Preparation of subculture 
In a sterile conditions under a laminar air cabinet, the test organisms were transferred from pure 
cultures to agar slants with the help of a transfer loop in order to have fresh, pure cultures. The 
inoculated strains were then incubated for 24 hours at 370C for optimum growth. These fresh 
cultures have been used for the sensitivity test. 
 
 
Figure 12. Preparation of subculture (source: microbenotes.com) 
 
6.3.8 Preparation of the test plate 
The test organisms were relocated from the subculture to the test tubes containing 
approximately 10 ml of melted and sterilized agar with the help of a sterilized transfer loop in the 
aseptic area. The test tubes were shaken by rotation to obtain a uniform suspension of the 
microbes. The bacterial and fungal suspension was immediately transferred to the sterilized 
petridises. Petridis were rotated several times clockwise and clockwise to ensure the 
homogeneous distribution of the test organisms in the media. 
 
 
Figure 13. (a) Preparation of the test plates (b) Freshly prepared culture medium, (c) Pouring 
culture medium to petridishes, (d) Transfer of bacterial and fungal suspension to the petridishes 
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6.3.9 Preparation of discs 
Measured amount of each test sample (specified in table 6.3) was dissolved in specific volume 
of solvent (Chloroform or methanol) to obtain the desired concentrations in an aseptic 
condition. Sterilized metrical (BBL, Cocksville, USA) filter paper discs were taken in a blank 
petridish under the laminar hood. Then discs were soaked with solutions of test samples and 
dried. 
 
Figure 14. Preparation of filter paper discs. 
 
Table 6.4: Preparation of sample Discs 
Plant part Test Sample 
Dose 
µg /disc 
Required amount 
for 20 disc  (mg) 
 
Flowers of 
Ficusracemosa 
Methanol extract soluble fraction 400 8.0 
Pet-ether soluble fraction 400 8.0 
Carbon-tetrachloride soluble fraction 400 8.0 
Chloroform soluble fraction 400 8.0 
Aqueous soluble fraction 400 8.0 
Standard Ciprofloxacin (50 g/disc) discs were used as positive control to ensure the activity of 
standard antibiotic against the test organisms as well as for comparison of the response 
produced by the known antimicrobial agent with that of produced by the test sample. Blank 
discs were used as negative controls which ensure that the residual solvents (left over the discs 
even after air-drying) and the filter paper were not active themselves. 
 
6.3.10 Diffusion and incubation 
The sample discs, the standard antibiotic discs and the control discs were placed gently on the 
previously marked zones in the agar plates pre-inoculated with test bacteria and fungi. The 
plates were then kept in a refrigerator at 40C for about 24 hours upside down to allow sufficient 
diffusion of the materials from the discs to the surrounding agar medium. The plates were then 
inverted and kept in an incubator at 370C for 24 hours. 
 
6.3.11 Determination of the zone of inhibition 
The antimicrobial potency of the test agents are measured by their activity to prevent the 
growth of the microorganisms surrounding the discs which gives clear zone of inhibition. After 
incubation, the Antimicrobial activities of the test materials were determined by measuring the 
diameter of the zones of inhibition in millimeter with a transparent scale [63]. 
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Figure 15.  Clear zone of inhibition 
 
 
Figure 16.  Determination of clear zone of inhibition 
Source: Authors’ own work 
 
6.4 Results and discussion of In vitro antimicrobial screening of Ficus racemosa 
The Methanol extract of leaf of Ficus racemosa (MESF) and different partitionates i.e. Petroleum 
ether (PESF), carbon tetrachloride (CTCSF), chloroform (CSF) and aqueous (AQSF) soluble 
partitionate of the methanol extract of leaf of Ficus racemosa were subjected to antimicrobial 
screening with a concentration of 400 g/disc in every case. The results are given in the Table 
6.5. The Aqueous soluble fraction (AQSF) exhibited the highest inhibition against microbial 
growth having a zone of inhibition ranged from 7.0 mm to 11.0 mm.  
Table 6.5: Antimicrobial activity of test samples of Ficus racemosa 
Test M.O 
Diameter of zone of inhibition (mm) 
MESF 
 
PESF 
 
CTCSF CSF AQSF Ciprofloxacin 
(Standard) 
Gram positive bacteria 
Bacillus subtilis - 7.00 - 7.00 - 37.00 
Sarcina lutea 7.00 8.00 8.00 8.00 11.00 36.00 
Staphylococcus aureus 7.00 7 7.00 9.00 7.00 42.00 
Bacillus cereus 8.00 - 7.00 8.00 - 37.00 
Gram negative bacteria 
Escherichia coli - 8.00 - 7.00 9.00 38.00 
Shigella dysenteriae 7 - 7.00 8.00 7.00 39.00 
Vibrio mimicus 9.00 8.00 8.00 8.00 - 40.00 
Vibrio parahemolyticus 8.00 7.00 - 7.50 9.00 38.00 
Salmonella typhi 9.00 8.00 7.50 - - 38.00 
The maximum zone of inhibition produced by AQSF was found to be 11.0 mm against Sarcina 
lutea (+). This partitioning also showed moderate antibacterial activity against Vibrio 
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parahemolyticus (-), Escherichia coli (-), having zone of inhibition of 9.0 mm. The AQSF also 
exhibited minimum inhibition against microbial growth Staphylococcus aureus (-), Shigella 
dysenteriae (-), having a zone of inhibition 7.0 mm. The Methanolic extract soluble fraction 
(MESF) also exhibited 2nd highest inhibition against microbial growth having a zone of inhibition 
ranged from 7.0 mm to 9.0 mm. The maximum zone of inhibition produced by MESF was found 
to be 9.0 mm against Salmonella typhi (-), Vibrio mimicus (-). This partitioning also showed 
moderate antibacterial activity having zone of inhibition of 8.0 mm against Bacillus cereus (+), 
Vibrio parahemolyticus (-). The MESF also exhibited minimum inhibition against microbial growth 
Sarcina lutea (+), Staphylococcus aureus (+), Shigella dysenteriae (-) having a zone of inhibition 
7.50 mm. The chloroform soluble fraction (CSF) exhibited the 3rd highest inhibition against 
microbial growth having a zone of inhibition ranged from 7.0 mm to 9.0 mm. The maximum zone 
of inhibition produced by CSF was found to be 9.0 mm against Staphylococcus aureus (+). This 
partitioned also showed moderate antibacterial activity having a zone of inhibition of 8.0 mm 
against Sarcina lutea, Bacillus cereus (+), Shigella dysenteriae (-), Vibrio mimicus (-). The CSF also 
exhibited minimum inhibition against microbial growth Vibrio parahemolyticus (-) having zone of 
inhibition 7.50 mm. The Petroleum ether soluble fraction (PESF) exhibited 4th highest inhibition 
against microbial growth having zone of inhibition ranged from 7.0 mm to 8.0 mm. The 
maximum zone of inhibition produced by PESF was found to be 8.0 mm against Sarcina lutea 
(+), Escherichia coli (-), Vibrio mimicus (-), Salmonella typhi (-). The PESF also exhibited minimum 
inhibition against microbial growth Bacillus subtilis (+), Staphylococcus aureus (+), Vibrio 
parahemolyticus (-) having zone of inhibition 7.00 mm. The Carbon tetra-chloride soluble 
fraction (CTCSF) exhibited the 5th highest inhibition against microbial growth having zone of 
inhibition ranged from 8.0 mm to 7.0 mm. The maximum zone of inhibition produced by CTCSF 
was found to be 8.0 mm against Sarcina lutea (+), Vibrio mimicus (-). This partitioning also 
showed moderate antibacterial activity against Salmonella typhi Staphylococcus aureus (+), 
Bacillus cereus (+), Shigella dysenteriae (-), having zone of inhibition of 7.5.0 mm and exhibited 
minimum inhibition against microbial growth Staphylococcus aureus (+), Bacillus cereus (+), 
Shigella dysenteriae having zone of inhibition 7.0 mm.  The results of in-vitro microbial screening 
of flowers of Ficus racemosa indicated that AQSF, MESF, CSF, PESF and CTCSF, possess better 
antimicrobial activity and these can be further studied to explore potent antimicrobial agents. 
Besides, all these test subjects have significant activity against gram-positive and gram-negative 
bacteria.  
 
7. Membrane Stabilizing Activity 
 
7.1 Introduction 
Inflammation is one of the most important processes in many pathological disorders. 
Inflammatory cells produce a complex mixture of cytokine growth and differentiation, as well as 
physiologically active arachidonate metabolites. Besides, they possess the ability to generate 
reactive oxygen species (ROS) that can damage cell biomolecules, which in turn increase the 
inflammation status [64]. Compounds that possess radical scavenging ability may, therefore, 
expect to have therapeutic potential for the inflammatory disease [65]. Erythrocyte membrane 
is similar to the lysosomal membrane and, as such, the effect of drugs on erythrocyte 
stabilization could be extrapolated to the stabilization of the lysosomal membrane [40]. As a 
result, the membrane stabilizes that interfere with the release and/or action of mediators such as 
histamine, serotonin, prostaglandins, leukotrienes, etc. [66]. The aim of this study was to 
investigate the anti-inflammatory activity of the methanol extract and its different fractions of 
ficus racemosa fruit. 
 
Forestry & Agriculture Review 1 (2), 2020 
60 Published by Scientific Research Initiative, 3112 Jarvis Ave, Warren, MI 48091, USA  
 
7.2 Materials and method 
 
7.2.1 Preparation of the extract 
Table 7.1: Preparation of different extracts of roots of Ficus racemose 
Sample code Concentration 
Hypotonic solution 2mg/ml 
MESF 2mg/ml 
PESF 2mg/ml 
CTCSF 2mg/ml 
CSF 2mg/ml 
AQSF 2mg/ml 
ASA (Acetyl Salicylic Acid) 0.1mg/ml 
 
Solvent used: Methanol analytical grade  
 
7.2.2 Drug 
Standard Acetyl Salicylic Acid (ASA) or Aspirin was used as standard drug for comparison with 
different methanolic extracts of roots of Ficusracemosa. 
 
7.2.3 Red Blood Cells (RBC) collection 
Human RBCs were collected for the study. RBCs collected from the human was male, 70 kg, 
fare complexion and free from diseases. The collected RBCs were kept in a test tube with an 
anticoagulant EDTA under standard conditions of temperature 23±2°C and relative humidity 
55±10%. 
 
7.2.4 Preparation of Phosphate buffer solution 
A buffer is an aqueous solution that has a highly stable pH. The buffer was prepared at pH 7 
using monosodium phosphate and its conjugate base, disodium phosphate. 
 
7.2.4.1 Phosphate buffer materials 
 Monosodium phosphate  
 Disodium phosphate  
 Water  
 pH meter  
 Glassware  
 Stirring bar  
 
7.2.4.2 Calculation of Phosphate buffer 
A pH of about 7.4 with buffer strength of 10 mM was obtained using 0.0352% monosodium 
phosphate dehydrate and 0.1099% disodium phosphate anhydrate. The buffer was made by 
adding 0.352 gm monosodium phosphate dehydrate and 1.099 gm disodium phosphate 
anhydrate to 1000 mL water. 
 pH: 7.4 
 Buffer strength: 10.00 mM 
 Monosodium phosphate, dehydrate: 0.0352% 
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 Disodium phosphate, anhydrate: 0.1099% 
 
7.2.5 Preparation of isotonic solution 
A solution that has a concentration of electrolytes, nonelectrolytes or a combination of the two 
that will exert equivalent osmotic pressure as that solution with which it is being compared. 
Either 0.16M sodium chloride (NaCl) solution (approximately 0.95% salt in water) or 0.3M non-
electrolyte solution is approximately isotonic with human red blood cells. 
For the preparation of 500 ml isotonic solution of 154 mM strength, 4.5045 gm NaCl was added 
and mixed.   
 
7.2.5.1: Material for isotonic solution 
 Sodium chloride (NaCl) 
 Water  
 Glassware  
 Stirring bar  
7.2.5.2 Calculation for isotonic solution 
1000 ml solution of strength 1 M contain = 58.5 gm NaCl 
500 ml solution of strength 1 M contain = 58.5/2 gm NaCl 
500 ml solution of strength 1000 mM contain = 58.5/2 gm NaCl 
500 ml solution of strength 154 mM contain   = 58.5 × 154/2 × 1000 gm NaCl 
                                                                              = 4.5045 gm NaCl 
7.2.6 Preparation of hypotonic solution 
A solution of lower osmotic pressure than that of a reference solution or of an isotonic solution is 
called hypotonic solution. 
For the preparation of 500 ml hypotonic solution, having strength of 50 mM, 1.4625 gm NaCl was 
added and mixed. 
 
7.2.6.1 Materials for hypotonic solution 
 Sodium chloride (NaCl) 
 Water  
 Glassware  
 Stirring bar  
 
7.2.6.2 Calculation for hypotonic solution  
1000 ml solution of strength 1 M contain = 58.5 gm NaCl 
500 ml solution of strength 1 M contain = 58.5/2 gm NaCl 
500 ml solution of strength 1000 mM contain = 58.5/2 gm NaCl 
500 ml solution of strength 50 mM contain = 58.5 × 50/2 × 1000 gm NaCl 
                                                                         = 1.4625 gm NaCl  
 
7.2.7 Effect on hemolysis 
 
7.2.7.1 Erythrocyte suspension 
Whole blood was collected from male human under standard condition. EDTA was used to 
prevent clotting. The blood was washed three times with isotonic solution (154 mM NaCl) in 10 
mM sodium phosphate buffer (pH 7.4) through centrifuge action for 10 min at 3000 rpm. Thus the 
suspension finally collected was the stock erythrocyte (RBC) suspension. 
 
7.2.7.2 Hypotonic solution Induced hemolysis 
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The experiment was carried out with hypotonic solution. The test sample consisted of stock 
erythrocyte (RBC) suspension(0.5ml) with 5ml of hypotonic solution(50mm NaCl) in 10 mm 
sodium phosphate buffer saline (pH 7.4) containing either the different methanolic extract 
(2mg/ml) or acetyl salicylic acid (.1mg/ml). The acetyl salicylic acid was used as reference 
standard. The mixture was incubated for 10 min of room temperature centrifuge for 10 min of 
3000 RPM and the absorbance of the separated was measured of 540nm using shimadzu UV 
spectrophotometer.  
The percentage inhibition of either hemolysis or membrane stabilization was calculated using 
the following equation. 
     % inhibition of haemolysis =100× {(OD1-OD2)/OD1} 
     Where, 
OD1= optical density of hypotonic buffered saline solution alone (control) and 
OD2= optical density of the test sample in hypotonic solution. 
 
7.3 Result and discussion of the test sample of Ficus racemosa 
The different methanolic extracts of the fruits of concentration 2.0 mg/ml significantly protected 
the lysis of human erythrocyte membrane induced by hypotonic solution as compared to the 
standard acetyl salicylic acid. The roots of Ficus racemosa were effective in the membrane 
stability activity as the extractive prevented the lysis of erythrocyte induced by hypnotic 
solution. The methanolic extract (MESF) inhibited 39.84%,  petroleum ether soluble 
fractionate(PESF) inhibited 19.70%, carbon tetrachloride soluble fractionate (CTCSF) inhibited 
46.63% and aqueous soluble fractionate (AQSF) inhibited 57.85 %  for membrane stabilizing 
activity acetyl salicylic acid was used as standard drug that exhibited 75.76 % inhibition of 
hemolysis of normal condition. 
Table 7.2: Effect of different extractions of Fruits of Ficus racemosa of hypnotic solution induced 
hemolysis of erythrocyte membrane. 
Sample Code Concentration Absorbance % Inhibition 
Hypotonic 50 mm 1.675 0 
MSF 2 mg/ml 1.125 32.84 
PESF 2 mg/ml 1.345 19.70 
CTSF 2 mg/ml 0.894 46.63 
AQSF 2 mg/ml 0.706 57.85 
ASF 2 mg/ml 0.406 75.76 
 
 
Figure 18. Hypotonic solution induced hemolysis 
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7.3.1 Heat induced hemolysis 
Aliquots of the isotonic buffer containing 2 mg/ml of different extractive of Ficus racemosa were 
put into two duplicates of centrifuging tube [66]. The vehicle in the same amounts was added 
to another tube as control. Erythrocyte suspension (30 µl) was added to each tube and mixed 
gently by inversion. One pair of tubes was incubated at 540C for 20 min in a water bath. The 
other pair was maintained of 0-5oC in an ice bath. The reaction mixture was centrifuged for 10 
min at 1300 RPM and the absorbance of the supernatant was measured at 540 nm. The 
percentage inhibition or acceleration of hemolysis in tests and was calculated according to the 
equation. 
% inhibition of hemolysis= 100× {1-×
𝑂𝐷2−𝑂𝐷1
𝑂𝐷3−𝑂𝐷1
} 
=100× {
𝑂𝐷3−𝑂𝐷1−𝑂𝐷2+0𝐷1
𝑂𝐷3−𝑂𝐷1
} 
=100×
𝑂𝐷3−𝑂𝐷2
𝑂𝐷3−)𝐷1
 
Where, 
OD1= test sample unheated  
OD2= test sample heated and 
OD3= control sample  
 
The different methanolic extracts of the roots of concentration 2.0 mg/ml significantly protected 
the lysis of human erythrocyte membrane induced by heat as compared to the standard acetyl 
salicylic acid. 
The fruits of Ficus racemosa were effective in the membrane stability activity as the extractive 
prevented the lysis of erythrocyte induced by hypnotic solution. The methanolic extract (MESF) 
inhibited 67.89 %,  petroleum ether soluble fractionate (PESF) inhibited 63.10 %, carbon 
tetrachloride soluble fractionate (CTCSF) inhibited 69.08 % and aqueous soluble fractionate 
(AQSF) inhibited 70.78%  for membrane stabilizing activity acetyl salicylic acid was used as 
standard drug that exhibited 85.41 % inhibition of hemolysis of normal condition. 
 
Table 7.3: Effect of different extraction of fruits of Ficus racemosa of heat induced hemolysis of 
erythrocyte membrane. 
 
Sample 
Code 
Concentration Unheated(OD1) Heated(OD2) 
OD3-
OD2 
OD3-
OD1 
% 
Inhibition 
Hypotonic 50 mm 3.971(OD3)       
MSF 2 mg/ml 0.433 1.569 2.402 3.538 67.89 
PESF 2 mg/ml 0.532 1.801 2.17 3.439 63.10 
CTSF 2 mg/ml 0.278 1.42 2.551 3.693 69.08 
AQSF 2 mg/ml 0.648 1.619 2.352 3.323 70.78 
ASA 0.10 mg/ml 1.16 1.57 2.401 2.811 85.41 
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Figure 19. Heat induced haemolysis 
 
The effect of synthetic and herbal anti-inflammatory agents on the stabilization of erythrocyte 
membrane exposed to hypotonic solution has been studied extensively. The erythrocyte 
membrane resembles to lysosomal membrane and as such, the effect of drugs on the 
stabilization of erythrocyte could be extrapolated to the stabilization of lysosomal membrane. 
The results showed that the extracts were potent on human erythrocyte adequately protecting 
it against hypotonic induced lysis. The activity was comparable to that of standard anti-
inflammatory drug (Acetyl Salicylic Acid). It has been reported that flavonoids exert profound 
stabilizing effects on lysosomes both in vitro and in vivo experimental animals while tannin have 
the ability to bind cations and other bio-molecules, and are able to stabilize erythrocyte 
membrane. The present investigation suggests that the membrane stabilizing activity of root of 
Ficus racemosa plays a significant role in its anti-inflammatory activity may be due to its high 
flavonoids and tannin content. 
 
8. Evaluation of thrombolytic Activity 
 
8.1 Introduction 
Herbal preparations have been used for the treatment of several diseases since ancient times. 
The leaves and/or twigs, the stem, the bark and the underground parts of the plants are most 
commonly used for traditional medicines. Herbal products are often perceived to be safe 
because they are "natural" [67]. Cerebral venous sinus thrombosis (CVST) is a common disorder 
associated with high morbidity and mortality [67]. Heparin, an anti-coagulant agent, is the first 
line of treatment for CVST due to its efficacy, safety and feasibility [69]. Thrombolytic drugs such 
as tissue plasminogen activator (t-PA), urokinase, streptokinase, etc. play a key role in the 
management of CVST patients [70]. The aim of this study was therefore to investigate the 
thrombolytic activity of methanol extracts and their different fractions of the roots of Ficus 
racemosa. 
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8.2 Materials & Methods 
 
8.2.1 Preparation of sample 
The thrombolytic activity of all extractives was evaluated using streptokinase (SK) as a standard 
substance. 10 mg of methanol extract and its different fractions of the whole plant of Ficus 
racemosa or taken in different vials to which 1 ml of distilled water was added. 
 
8.2.2 Streptokinase (SK) 
Commercially produced Altepase (Streptokinase) vial (Beacon Pharma Ltd) of 15, 00,000 I.U. 
was collected and 5 ml of sterile distilled water was added and properly mixed. This suspension 
was used as a stock from which 100μl (30,000 I.U.) was used for thrombolytic in vitro. 
 
8.2.3 Blood Sample 
Whole blood (n=10) was drawn from healthy human volunteers without a history of oral 
contraceptive or anticoagulant therapy and 1ml of blood was transferred to the previously 
weighed sterile vials  and was allowed to form clots. 
 
8.2.4 Thrombolytic activity 
Aliquots (5 ml) of venous blood were drawn from healthy volunteers who were distributed in 10 
different pre-weighted sterile vials (1 ml / tube) and incubated at 37 ° C for 45 minutes. After the 
formation of the clot, the serum was completely removed without disturbing the clot, and each 
vial containing the clot was again weighed to determine the weight of the clot (clot weight = 
weight of the clot containing the tube – weight of the tube alone). 100 μl of aqueous solutions 
of Ficus racemosa, along with crude extracts, were added separately to each vial containing 
pre-weighed clot. As a positive control, 100 μl of streptokinase (SK) and as a negative non 
thrombolytic control, 100 μl of distilled water were added separately to the control vials. All the 
vials were then incubated at a temperature of 37 ° C for 90 minutes and observed for clot lysis. 
After incubation, the released of fluid was removed and vials were again weighed to observe 
the difference in weight after clot disruption. Difference obtained in weight taken before and 
after clot lysis was expressed as percentage of clot lysis as shown below:  
       % of clot lysis = (wt of released clot /clot weight) × 100 
 
8.3 Results and Discussion of thrombolytic activity of Ficus racemosa 
As a part of discovery of cardio protective drugs from natural sources the extractive of the leaf 
either assess or not for thrombolytic activity and results are presented in the table (8.1).  
Table 8.1: Thrombolytic Activity (in terms of % of clot lysis) of the extractives of Ficus racemosa. 
Fractions Weight of 
empty vial W1 
gm 
Weight of  
vial with  clot 
W2  gm 
Weight of clot 
W3= W2-W1 
gm 
Weight of  
vial after clot 
lysis W4  gm 
Weight of lysis 
clot W5 = W2-
W4 gm 
%of clot lysis= 
100  X W5/W3 
MESF 5.05 7.42 2.37 6.64 0.78 32.91 
PESF 5.10 7.23 2.13 6.50 0.73 34.27 
CTSF 5.07 7.22 2.15 6.56 0.66 30.70 
CSF 4.50 5.53 1.03 5.13 0.40 38.83 
AQSF 5.15 6.85 1.70 6.32 0.53 31.18 
Blank 5.26 7.12 1.86 6.93 0.19 10.23 
SK 5.34 7.25 1.90 6.00 1.25 65.69 
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Figure 20. Thrombolytic Activity (in terms of % of clot lysis) of extractives of Ficus racemosa. 
 
Adding 100M1SK, positive control (30000.00) to the clot, and subsequent incubation at 37 ° C for 
90minutes showed that 65.69 per cent of clot lyse, on the other hand, distilled water was treated 
as negative control, which showed (10.23 per cent) a negligible percentage between positive 
and negative control was found to be very significant. In this study, thrombolytic activity among 
all ficus racemosa rot extractives was found to be negligible. Thrombolytic activity levels were 
present in the Methanol soluble fraction (MESF 32.91 percent), the Pet-Ether soluble fraction 
(PESF 34.27 percent), the carbon tetra chloride soluble fraction (CTCSF 30.70 percent) and the 
dichloromethane soluble fraction (CSF 38.83 percent) and the Aqueous soluble fraction (AQSF 
31.18 percent). From this experiment, it can be concluded that the extractives of Ficusracemosa 
showed less clot lysis activity than the standard substance streptokinase (SK). 
 
9. Evaluation of Peripheral Analgesic Activity 
 
9.1 Introduction 
Inflammation is the response of a tissue and its microcirculation to pathogenic injury. It is 
characterized by the generation of inflammatory mediators and movement of fluid and 
leucocytes from the blood into extra vascular tissues which gives rise to the four cardinal signs of 
inflammation, namely rubor (redness), calor (heat), tumor (swelling) and dolor (pain) as 
described by AnlusCelsus, the Roman encyclopedist, in the second century AD. Inflammation 
may be classified into acute, sub-acute and chronic or immunological. There are various 
mediators for these types of inflammation in different stages, which are histamine, 5-
hydroxytryptamine, bradykinin, prostaglandins, leukotrienes, etc 
 
9.2 Principle 
Peripheral analgesic activity can be evaluated by acetic acid induced writhing method [71].In 
this method acetic acid is administered intra-peritoneal to the experimental animals to create 
pain sensation. As a result, the animals squirms their body at regular interval out of pain. This 
squirm or contraction of the body is termed as “writhing”. As long as the animals feel pain, they 
continue to give writhing. Each writhing is counted and taken as an indication of pain sensation. 
Any substance that has got analgesic activity is supposed to lessen the number of writhing of 
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animals within in a given time frame and with respect to the control group. The writhing   
inhibition of positive control was taken as standard and compared with test samples and 
control. As positive control, any standard NSAID drug can be used. In the present study, 
Diclofenac was used as a standard drug [72]. According to this principle the crude methanolic 
extract of roots of Fecus racemosa was subjected to analgesic testing at two different doses: 
Dose 200 mg/kg and 400 mg/kg of body weight. 
 
9.3 Experimental Animal 
Swiss-albino mice of either sex, aged 4-5 weeks, obtained from the Animal Resource Branch of 
the International Centre for Diarrhoeal Diseases and Research, Bangladesh (ICDDRB) were used 
for the experiment. They were housed in standard polypropylene cages and kept under 
controlled room temperature (24 ± 2ºC; relative humidity 60-70%) in a 12 h light-dark cycle and 
fed ICDDR; B formulated rodent food and water (ad-libitum). As these animals are 
very sensitive to environmental changes, they are kept before the test for at least 3-4 days in the 
environment where the experiment will take place. 
  
(a) Swiss albino mice (b) Oral administration 
Figure 20. Feeding Experimental Animal 
 
9.4 Experimental Design 
Twelve experimental animals were randomly selected and divided into four groups denoted as 
group-I, group-II and group-III (A-B) consisting of 3 mice in each group. Each group received a 
particular treatment. Prior to any treatment, each mouse was weighed properly and the doses 
of the test samples and control materials were adjusted accordingly. As it was difficult to 
observe the biologic response of three mice at a time receiving same treatment, it was 
necessary to identify individual animal of a group during the treatment. The animals were 
individualized in the following way (Figure 21) and marked as M-1= Mice 1, M-2= Mice 2, M-3= 
Mice 3. 
 
 
 
Figure 21. Numbering of mice 
 
M-2= Mice 2 
 
M-1= Mice 1 
 
M-3= Mice 3 
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9.4.1 Preparation of Test Materials 
In order to administer the extract at doses of 400 mg/kg body wt and 200 mg/kg body wt of 
mice, the exactly weighed extracts were measured respectively and triturated in 
unidirectional way by adding of small amount of Tween-80 (a suspending agent). After 
proper mixing of extract and suspending agent, normal saline was slowly added. The final 
volume of the suspension was made up to 3.0 ml. To stabilize the suspension, it was stirred well 
by vortex mixture. For the preparation of Diclofenac at the, 50 mg of diclofenac was taken 
and a suspension of dose of 50 mg/kg-body weight was made. 
 
9.4.2 Procedure 
 
Figure 22. Schematic representation of procedure for screening of analgesic property 
 
9.4.3 Counting of licking and biting responses 
Each mouse of all groups were observed individually for counting the number of licking and 
biting responses they made in 5 minutes commencing just after the subcutaneous 
administration of formalin solution. 
 
 
Figure 23. Mechanism of action of pain induction. 
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9.5. Data collection 
Table 9.1: Test materials used in the evaluation of analgesic activity of flowers of Fecus 
racemosa. 
Code no. Test Samples Group Identification Dose (mg/kg)* 
CTL 
1% Tween-80 in normal 
saline 
I Control Group 
0.1 ml/10 g of  
body wt 
STD Diclofenac sodium II Standard  Group 50 
MESF 1 Methanolic extract III A Test Sample 200 
MESF 2 Methanolic extract III B Test Sample 400 
 
*All doses were given orally. 0.1 ml of 1% acetic acid solution was injected into the peritonial to each mouse. 
 
Table 9.2: Screening of analgesic activity by counting the time of licking and biting after 
subcutaneously administration of 5% acetic acid 
Animal 
Group 
Writhing Count Average Standard 
Deviation 
Standard 
Error 
Writhing 
(%) 
% Inhibition 
M-
1 
M-
2 
M-
3 
Control (H2O) 
17 12 16 15 1.24 0.88  - 
Standard 
(Diclofenac) 3 2 4 3 0.471 0.33  80 
MESF (200 mg) 
5 4 6 5 0.471 0.33  66.66 
MESF (400 mg) 
3 6 4 4.33 0.72 0.50  71.13 
 
In the table M-1 = mice 1, M-2 = mice 2 and M-3 = mice 3. 
According to the data that the above table, the Methanolic extracts of leaf of 
Fecusracemosa at dose of 400 mg/kg exhibited significant peripheral analgesic activity and 
at doses of 200mg/kg also showed peripheral analgesic activity to a lesser extent compared 
to Diclofenac Na. 
 
Table 9.3: Statistical evaluation for the peripheral analgesic activity test 
Code no. Writhing (%) 
Inhibition 
(%) 
t value P value 
Level of 
significance 
Standard 
(Diclofenac) 
- 80 11.0322 .004058 
Very statistically 
significant 
MESF (200 
mg) 
- 66.66 18.3870 .001472 
Very statistically 
significant 
(MESF 400 
mg) 
- 71.13 10.4164 .004546 
Very statistically 
significant 
 
Statistical evaluation of the data obtained after the administration of the samples confirmed 
that the Methanolic extract of roots of Fecus racemosa at doses of 200 mg/kg and 400 mg/kg 
were showed a percent Inhibition of 4.55% and 9.09% respectively. Both data was extremely 
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statistically significant. 
 
 
Figure 24. Comparison of %inhibition of licking responses by Methanolic extract of 
Fecus racemosa 
 
9.6. Result and Discussion 
The different test samples were subjected to screening for analgesic activity by acetic acid 
test. The test was performed by taking samples at doses 200 mg/kg and 400 mg/kg body 
weight. The result was statistically evaluated and the t-test and p values were determined. All 
the test materials exhibited highly significant peripheral analgesic activity at both the two 
doses while the crude extract at 400 mg/kg dose exhibited maximum inhibition of licking and 
biting71.13%. 
 
10. Evaluation of central Analgesic Activity 
 
10.1 Principle 
Evaluation of central analgesic activity was carried by tail immersion method using Morphine 
as a positive control. The changes in sensitivity of test animal due to analgesic activity of 
drugs are measured in this method. A constant heat stress is applied to rat tail, which acts as 
pain stimulus. When the stimulus exceeds the threshold, rat show a quick withdrawal of its tail. 
Time taken by the rat to withdraw the tail is termed as tail immersion time. Analgesic 
compound elongates this responding time. By this test discrimination was done between 
centrally acting morphine –like analgesics and non-opiate analgesics. The test rats were orally 
fed with test materials whereas the positive control received morphine subcutaneously. From 
1-2 cm of the tail of mice was immersed in warm water kept constant at 550 C . The reaction 
time is the time required by the mice to deflect their tails. The time required to withdraw the 
tail was recorded. 
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10.2 Experimental animal  
Swiss-albino mice of either sex, aged 4-5 weeks, obtained from the Animal Resource Branch 
of the International Centre for Diarrhoeal Diseases and Research, Bangladesh (ICDDR, B) were 
used for the experiment. They were housed in standard polypropylene cages and kept under 
controlled room temperature (24 ± 2ºC; relative humidity 60-70%) in a 12 h light-dark cycle 
and fed ICDDR,B formulated rodent food and water (ad-libitum). As these animals were very 
sensitive to environmental changes, they were kept before the test for at least 3-4 days in the 
environment where the experiment will take place. Food was withdrawn 12 hours before and 
during the experiment. The ethics for use of experimental animals were followed carefully. 
 
10.3 Experimental Design 
Fifty  experimental animals were randomly selected and divided into ten groups denoted as 
group-I, group-II, group-III(A-B), group- IV(A-B), consisting of 3 mice in each group. Each group 
received a particular treatment. Prior to any treatment, each mouse was weighed properly 
and the doses of the test samples and control materials were adjusted accordingly. As it was 
difficult to observe the biologic response of three mice at a time receiving same treatment, it 
was necessary to identify individual animal of a group during the treatment. The animals were 
individualized in the following way (Figure 12.2) and marked as M1=Mice 1, M2=Mice 2, and 
M3=Mice 3. 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Numbering of mice 
 
10.3.1 Materials and equipment 
 Mice holder 
 Feeding needle 
 Syringe 
 Morphine 
 Mice cage 
 
10.4 Experimental Procedure 
 
10.4.1 Preparation of Test Materials 
In order to administer the extract at doses of 400 mg/kg body wt and 200 mg/kg body wt of 
mice, the exactly weighed extracts were measured respectively and triturated in 
unidirectional way by adding of small amount of Tween-80 (a suspending agent). After 
proper mixing of extract and suspending agent, normal saline was slowly added. The final 
M-1= Mice 1 
 
M-1= Mice 1 
 
M-1= Mice 1 
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volume of the suspension was made up to 3.0 ml. To stabilize the suspension, it was stirred well 
by vortex mixture. Diclofenac-Na (Clofenac Plus of Square Pharmaceuticals Ltd) was 
administered orally in the form of solution. The solution was prepared by diluting the supplied 
diclofenac-Na (4 mg in 10 ml) with saline water. Then diclofenac-Na which ensured a dose of 
2mg/kg for 32 mg mice. 
 
10.4.2 Methodology 
Test samples and control were given orally by means of a feeding needle to the mice at zero 
hour. At zero hour, 1-2 cm of the tail of mice was immersed in warm water kept constant at 
550 C. The reaction time is the time required by the mice to deflect their tails. The first reading 
is discarded and the reaction time is recorded as a mean of the next three reading. A 
latency period of 20 seconds was defined as complete analgesia and the measurement was 
stopped to avoid injury to mice. The latent period of tail-flick response was determined before 
and 0, 30, 60 and 90 minutes after the administration of drugs.  A 30 minutes interval was given 
to ensure proper absorption of the administered substances. Then diclofenac-Na solution was 
administered subcutaneously to the mice. After 30 minutes, 60 minutes and 90 minutes, the 
tail immersion time was measured. 
The time for tail immersing of each mouse was recorded and the average immersing time of 
each group was calculated. The % time elongation of tail immersing was calculated in 
respect to the control. The higher the elongation percentage of the group the greater is the 
group’s central analgesic activity. The central analgesic activity of the test samples were 
compared in respect to diclofenac-Na. 
 
%Time elongation =  
 
 
Table 10.1: Test materials used in the evaluation of central analgesic activity of crude extract 
and its different fractions of Ficus racemosa. 
Code no. Test Samples Group Identification Dose 
(mg/kg)* 
Route 
of 
administration 
Control Distilled Water I Control Group 50 ml Oral 
Standard Diclofenac Na II Standard  Group 2 mg Oral 
MESF 
200mg 
Methanolic extract III A Test Sample 200 mg Oral 
MESF 
400mg 
Methanolic extract III B Test Sample 400 mg Oral 
 
Table 10.2: Analysis of the data obtained after 30 minutes 
Animal 
Group 
Immersion time count 
(seconds) 
Average 
time of 
immersion 
Standard 
deviation 
Standard 
deviation 
error 
% Elongation 
Control 
(Water) 
M-1 M-2 M-3 
2.65 0.14 0.099 - 
2.62 2.56 2.78 
Standard 
(Diclofenac) 
4.43 4.69 5.32 4.81 0.215 0.152 81.50 
MESF 
(200 mg) 
2.85 3.79 2.94 3.19 0.285 0.20 20.30 
MESF 
(400 mg) 
3.96 4.53 3.63 4.04 0.214 0.151 52.45 
Average time of tail flicking of test samples - Average time of tail immersing of the control group 
Average time of tail flicking of control group 
X100% 
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According to the data in the above table the methanol soluble fraction at dose of 400mg/kg 
exhibited highly significant central analgesic activity. The crude extracts at doses of 
400mg/kg also exhibited significant central analgesic activity after 30 minutes compared to 
diclofenac Na. The MESF at doses of 200mg/kg also showed central analgesic activity to a 
lesser extent.  
Table10.3: Statistical Evaluation of the data obtained after 30 minutes 
Group 
t-Test 
value 
Degree of 
freedom 
P value Level of significance 
Standard 
(Diclofenac) 
38.7496 2 0.000333 Extremely statistically significant 
MESF 
(200 mg) 
19.3868 2 0.001325 Very Statistically significant 
MESF 
(400 mg) 
32.6985 2 0.000467 Extremely statistically significant 
 
Statistical evaluation of the data obtained 30 minutes after the administration of the samples 
confirmed that the methanolic extract at doses of 400 mg/kg exhibited significant central 
analgesic activity. The crude at doses of 200 mg/kg showed central analgesic activity to a 
lesser extent. 
Table 10.4: Analysis of the data obtained after 60 minutes 
Animal 
Group 
Immersion time count 
(seconds) 
Average 
time of 
immersion 
Standard 
deviation 
Standard 
deviation 
error 
% Elongation 
Control 
(Water) 
M-1 M-2 M-3 
2.60 0.184 0.130 - 
2.97 2.19 2.64 
Standard 
(Diclofenac) 
3.79 4.88 4.56 4.39 0.264 0.186 68.84 
MESF 
200 mg 
3.87 3.14 3.10 3.37 0.204 0.144 29.61 
MESF 
400 mg 
3. 50 4. 70 3.95 4.05 0.285 0.201 55.77 
 
In the table M-1 = mice 1, M-2 = mice 2, M-3 = mice 3 
The data in Table: 10.4 showed that after 60 minutes the central analgesic action of Crude 
Methanol extract at a dose of 400 mg/kg became stronger. They showed a percent 
elongation of 55.77% and 29.61% at a dose of 400 mg and 200 mg/kg bode weight. But the 
central analgesic activity of aqueous soluble fraction at 400 mg/kg dose still remains highly 
significant after 60 minutes. 
Table 10.5: Statistical Evaluation of the data obtained after 60 minutes 
Group 
t-Test 
value 
Degree of 
freedom 
P value Level of significance 
Standard 
(Diclofenac) 
28.8019 2 0.000602 Very statistically significant 
MESF 
(200 mg) 
28.6128 2 0.00061 Very statistically significant 
MESF 
(400 mg) 
24.6134 2 0.000823 Very statistically significant 
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Table 10.6: Analysis of the data obtained after 90 minutes 
Animal 
Group 
Immersion time count (seconds) 
Average 
time of 
immersion 
Standard 
deviation 
Standard 
deviation 
error 
% 
Elongation 
Control 
(Water) 
M-1 M-2 M-3 
2.35 0.225 0.159 - 
1.93 2.87 2.25 
Standard 
(Diclofenac) 
4.78 3.82 4.81 4.47 0.265 0.187 90.21 
MESF 
200 mg 
3.67 4.86 2.37 3.63 0.587 0.415 54.46 
MESF 
400 mg 
3.87 3.12 5.09 4.02 0.468 0.33 71.06 
 
In the table M-1 = mice 1, M-2 = mice 2, M-3 = mice 3 
The data in Table: 10.6 showed that after 90 minutes the central analgesic action of Crude 
Methanol extract at a dose of 400 mg/kg became stronger. It showed a percent elongation 
of 71.06%. At a dose of 200 mg/kg showed a percent elongation of 54.46%.  
 
Table 10.7: Statistical Evaluation of the data obtained after 90 minutes 
Group 
t-Test 
value 
Degree of 
freedom 
P value Level of significance 
Standard 
(Diclofenac) 
29.2161 2 .000585 Very statistically significant 
MESF 
(200 mg) 
10.7110 2 .004302 Very statistically significant 
MESF 
(400 mg) 
14.8779 2 .002244 Very statistically significant 
 
The statistical evaluation of the data showed that the central analgesic activity of the 
samples declined after 90 minutes. 
 
 
Figure 26. Comparison of percent time elongation of tail immersion of differe nt 
samples 
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The analysis and statistical evaluation of the data leads to the following important 
conclusions. 
 The crude methanol extract has significant central analgesic activity at 400 mg/kg dose.  
 The central analgesic activity is highest after 90 minutes. 
 As the time progress the analgesic activity decreases. After 90 minutes there is almost no 
central analgesic activity in the plant extracts. 
11. Evaluation of Hypoglycemic Activity: 
 
11.1 Principle 
Diabetes mellitus is the most common endocrine disorder in men and women and the major 
public health problem of epidemic proportion. Once believed to be a disease of west, it is 
becoming an endemic to modernizing and urbanizing population in our country. Ayurvedic 
literature reveals that many herbal medicines in different oral formulation have been shown 
to comprise potent hypoglycemic activity and therefore recommended in madhumeha 
(diabetes mellitus) and confident claims of cure are on record. 
A glucose tolerance test (GTT) is one of the most acceptable methods to evaluate the 
hypoglycemic activity. It is a medical test in which glucose is given and blood samples taken 
afterward to determine how quickly it is cleared from the blood. The test is usually used to test 
for diabetes, insulin resistance, and sometimes reactive hypoglycemia or rarer disorders of 
carbohydrate metabolism. Many variations of the GTT have been devised over the years for 
various purposes, with different standard doses of glucose, different routes of administration, 
different intervals and durations of sampling, and various substances measured in addition to 
blood glucose. 
At the present study, hypoglycemic effect of methanolic extract of roots of Ficusracemosa at 
250 mg/kg and 500 mg/kg doses were examined & compared with relative to that of control 
and standard group. Here Glibenclamide was used as a standard drug. 
 
11.2 Experimental Animal 
Swiss-albino mice of either sex, aged 4-5 weeks, obtained from the Animal Resource Branch 
of the International Centre for Diarrhoeal Diseases and Research, Bangladesh (ICDDR,B) were 
used for the experiment. They were housed in standard polypropylene cages and kept under 
controlled room temperature (24 ± 2ºC; relative humidity 60-70%) in a 12 h light-dark cycle 
and fed ICDDR; B formulated rodent food and water (ad-libitum). As these animals are very 
sensitive to environmental changes, they are kept before the test for at least 3-4 days in the 
environment where the experiment will take place. 
 
11.3 Experimental Design 
Twelve experimental animals were randomly selected and divided into ten groups denoted 
as group-I, group-II, group-III (A), and group- III (B) consisting of 3 mice in each group. Each 
group received a particular treatment. Prior to any treatment, each mouse was weighed 
properly and the doses of the test samples and control materials were adjusted accordingly. 
As it was difficult to observe the biologic response of three mice at a time receiving same 
treatment, it was necessary to identify individual animal of a group during the treatment. The 
animals were individualized in the following way (Figure 13.3) and marked as M-1=Mice 1, M-
2=Mice 2, and M-3=Mice 3. 
    
11.3.1 Preparation of Test Materials 
In order to administer the extract at doses of 400 mg/kg body wt and 200 mg/kg body wt of 
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mice, the exactly weighed extracts were measured respectively and triturated in 
unidirectional way by adding of small amount of Tween-80 (a suspending agent). After 
proper mixing of extract and suspending agent, normal saline was slowly added. The final 
volume of the suspension was made up to 3.0 ml. To stabilize the suspension, it was stirred well 
by vortex mixture.  
For the preparation of standard (Glibenclamide) at the dose of 10-mg/kg body weight, 10 
mg tablet was dissolved into 3.0 ml distilled water. 
 
11.3.2 Procedure 
 
Figure 27. Schematic representation for determining blood glucose root of mice after 
administration of Ficus racemosa extract. 
 
Figure 28. Pricking of mice’s tail  
 
11.4 Result & Discussion of hypoglycemic activity of test materials of Ficus racemosa. 
The effects of methanolic extract of stem roots of Ficus racemosa at 200 and 400 mg/kg 
dose and its different fractionates at 200 mg/kg doses to lower blood glucose level were 
observed as follows to evaluate their hypoglycemic activity- 
 
Table 11.1: Test materials used in the evaluation of hypoglycemic activity of crude extract and 
its different fractions of Ficus racemosa. 
Code no. Test Samples Group Identification Dose (mg/kg)* 
CTL 1% Tween-80 & DMSO in 
normal saline 
I Control Group 0.1 ml/10 g of  body 
wt 
STD Glibenclamide II Standard  Group 10 
MESF 200mg Methanolic extract of Ficusracemosa. III A Test Sample 200 
MESF 400mg Methanolic extract of Ficusracemosa. III B Test Sample 400 
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Table 11.2: Plasma level of glucose (mmol/L) of mice at different times. 
Group  0 Min 
Glucose+ 25 
min 
24 Hours 48 Hours 72 Hours 
Control 
( H2O) 
 Data Mean Data Mean Data Mean Data Mean Data Mean 
M-1 8.3 
6.86 
11.4 
9.8 
7.8 
7.8 
7.9 
7.83 
6.4 
6.2 M-2 5.3 9.8 8.9 7.8 6.0 
M-3 7.0 8.2 6.7 7.8 6.2 
Standard 
M-1 7.1 
6.56 
8.9 
10.9 
8.7 
6.63 
8.2 
7 
6.5 
6.36 M-2 6.7 14.4 5.3 5.8 6.2 
M-3 5.9 9.5 5.9 7.1 6.4 
200 mg 
M-1 8.3 
8.6 
11 
11.3 
6.7 
6.7 
5.5 
7 
6.3 
6.4 M-2 8.6 11.6 7 7.2 6.4 
M-3 8.9 113 6.4 8.3 6.5 
400 mg 
M-1 10.4 
10.43 
13.3 
13.8 
8.8 
7.73 
10.5 
8.7 
7.8 
7.93 M-2 10.9 16.2 7 6.9 7.7 
M-3 10 11.9 7.4 8.7 8.3 
  
Table 11.3: Hypoglycemic activity of crude extract and its different fractions of Ficus racemosa. 
 
Code Plasma level of glucose (Mean) Mean SD SE 
 0 min Glucose+ 
25 min 
24 Hour 48 Hours 72 Hours    
Control 6.86 9.8 7.8 7.83 6.2 7.8 0.545 0.2725 
Standard 6.56 10.9 6.63 7 6.36 7.49 0.7679 0.383 
200 mg 8.6 11.3 6.7 7 6.4 8 0.812 0.406 
400 mg 10.43 13.8 7.73 8.7 7.93 9.71 1.006 0.503 
 
Table 11.4: Statistical evaluation of the Data 
Code SE 
t Test 
value 
Degree of 
freedom 
P value Level of significance 
Control  - 4  - 
Standard  21.8103 4 .000013 Extremely statistically  significant 
200 mg  22.0302 4 .000013 Extremely statistically significant 
400 mg  21.5827 4 .000014 Extremely  statistically significant 
 
The methanolic extrat of roots of Ficus racemosa has statistically significant blood glucose 
lowing activity at dose of 400 mg/kg. But significant hypoglycemic activity was exhibited by any 
other test subject. So, it can be concluded that the crude methanolic extract possesses 
moderate hypoglycemic activity at 400 mg. 
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Fig 29.  Plasma level of glucose of different groups of mice at different times  
 
12. Conclusion 
All the conducted experiments in the present study which are based on not only cured extract 
but also many different kinds of soluble frictions are considered to gain a concrete conclusion 
about the findings of the present study. It can be concluded from the above findings, the plant 
Ficus recaemosa have moderate to significant thrombolytic, membrane stabilizing, antioxidant, 
antimicrobial, analgesic and hypoglycemic activity. So, further scientific studies are necessary 
to explain detailed not only mechanism of action but also isolation the responsible active 
principles. 
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